Support to Ebola Treatment Unit Project (STEP): One Step Closer to an Ebola-Free Liberia Liberia Project End-line Evaluation Report Agreement: AID-OFDA-G-15-00021 Contact: Ms. Karen Romano, Country Director, Monrovia, Liberia Mr. Tim Ogborn, Vice President and Managing Director, Washington D.C. SUBMITTED TO: USAID Office of Foreign Disaster Assistance July 29, 2016 i | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Table of Contents Table of Contents ........................................................................................................................................... i Table of tables and figures ............................................................................................................................ ii List of Acronyms ......................................................................................................................................... iii 1.0 Executive summary ........................................................................................................................... 1 2.0 Introduction ....................................................................................................................................... 4 2.1 Background ................................................................................................................................... 4 2.2 Program description: ..................................................................................................................... 4 3.0 Evaluation Scope and Objectives ...................................................................................................... 6 4.0 Evaluation Methodology ................................................................................................................... 7 4.1 Study population and data sources ................................................................................................ 7 4.2 Sampling and data collection methods .......................................................................................... 8 4.3 Limitations of the evaluation ........................................................................................................ 9 5.0 Results and Interpretation: .............................................................................................................. 10 5.1 STEP performance and contribution to EVD outbreak control and prevention ......................... 10 5.1.1 Review of project performance ........................................................................................... 10 5.1.2 Contribution to EVD prevention and post-outbreak basic health services restoration ....... 16 5.2 Effort in building health workers’ and health facilities’ capacity in Nimba County; ................. 19 5.3 Continued utilization/application of the skills obtained through training and mentorship ......... 23 5.4 Key lessons learned for future programming .............................................................................. 24 6.0 Conclusions and Ways forward ...................................................................................................... 27 6.1 Conclusions ................................................................................................................................. 27 6.2 Way forward ............................................................................................................................... 28 Annexes ...................................................................................................................................................... 30 Annex 1: Survey tools and questionnaires ............................................................................................. 30 A1.1 STEP End-line Evaluation Key Informant Interview Guide ............................................... 30 A1.2 STEP End-line evaluation Key Informant Interview Questionnaire ................................... 32 A1.3 STEP End-line Evaluation FGD Guide............................................................................... 36 A1.4 STEP FGD Questionnaire ................................................................................................... 39 Annex 2: List of Indicators and Results ................................................................................................. 40 Annex 3: Medical Commodities and supplies used/distributed by STEP .............................................. 48 Annex 4: List of health facilities Supported by STEP by type of supported ......................................... 66 ii | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Table of tables and figures Table 1. Summary of STEP partners and coordinated activities .................................................................. 6 Table 2: Distribution of Key Informant Interviews ...................................................................................... 8 Table 3: Beneficiaries targeted and reached ............................................................................................... 10 Table 4: Number of people received clinical consultations by age, sex and consultation site ................... 13 Table 5: Training Participants by sex and Profession ................................................................................. 20 Table 6: Health Facilities and Health Care Workers Mentored by STEP ................................................... 22 iii | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia List of Acronyms CB-AECS: Community Based Active EVD Case Surveillance CDC: Center for Disease Control CHT: CoP County Health Team Chef of Party DHT District Health Team EVD: Ebola Virus Disease FGD Focus Group Discussion gCHVs General Community Health Volunteers GETU: Ganta Ebola Treatment Unit HC Health Center HF Health Facility IPC Infection Prevention and Control KII Key Informant Interview KSKS: Keep Safe – Keep Serving MOHSW Ministry of Health and Social Welfare OIC Officer In Charge PCI: Project Concern International PPE Personal Protective Equipment SQS: Safe and Quality Service STEP: Support To Ebola Treatment Unit Project TTMs Trained Traditional Midwifes UNICEF: UMU United Nations Children’s Fund United Methodist University WHO: World Health Organization 1 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 1.0 Executive summary In response to the Ebola Virus Disease (EVD) emergency in Liberia, Project Concern International (PCI) implemented Support to Ebola Treatment Project (STEP) in Nimba County, funded by the USAID Office of Foreign Disaster Assistance (USAID/OFDA). Through STEP, PCI managed the Ganta Ebola Treatment Unit (GETU) in close partnership with the Liberian Ministry of Health and Social Welfare (MOHSW), endeavoring to slow the spread of EVD in Nimba County through the isolation of cases, the provision of a high standard medical care and the psychosocial support to EVD suspected and confirmed individuals and affected families at the GETU. In addition, STEP, leveraged skills and experience of its project staff and leadership to expand support to the County Health Team (CHT). Support included system strengthening and implementing IPC outreach programs to communities and health facilities throughout Nimba County. The project started in December 2014 and ended April 30, 2016. The project initially targeted to benefit 9,180 individuals in the area, but reached a total of 15,388 people (68% increase over target) by the end of the project period. The end-line evaluation was conducted in Mid-March/April 2016, to assess project performance, the project’s contribution to the control of the EVD outbreak, the contribution towards strengthening the health system of Nimba County, and to draw key lessons. The findings of this evaluation are reported herein. The evaluation’s population of study mainly comes from the county health systems: the CHT, District Health Team (DHT), health facilities, the staff who worked at the GETU 1 , and community health facilitators or leaders. Primary data from key informant interviews (KII) and focus group discussions (FGD) using purposive sampling technique, and secondary data from the project quarter reports, IPTT, training database, and other sources were used as source data. All data collected were summarized and analyzed, and findings are presented in this report. In summary, STEP project activities supported 78 health facilities (69 primary, five secondary and four tertiary level) in Nimba County, serving a catchment area of 200,000 people through different interventions and project activities as indirect beneficiaries. Activities included the provision of high standard clinical services the GETU, community outreach for social mobilization on EVD prevention; community based active case surveillance, trainings such as Keep Safe – Keep Serving (KSKS), Safe and Quality Service (SQS) 2 , technical support to selected health facilities and health care workers (HCW) through mentorship and supportive supervision, IPC and basic medical supply provision, and other capacity building interventions. Project achievements include: 1 The Ganta ETU had been decommissioned since January 2016, and turned into a nursing training center by G. W. Harley Nursing School, UMU – the proprietor of the property. 2 SQS (Safe and Quality Service) is a post-EVD outbreak health service delivery protocol, and is the replacement for Keep Safe Keep Serving (KSKS) protocol that had been used during the EVD outbreak for health service delivery. 2 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia • provided consultation services to 8,865 (4,030 male and 4,835 female) people at the facility (Gant ETU) and using outreach approaches; • organized 24 community events for social mobilization and outreach level services; • reached 46 of the health facilities through comprehensive IPC mentorship benefiting 867 (428 male and 439 female) health care workers - more than double of the targets; • facilitated and supported the setup and erection of temporary triage and screening unities, waste management, and other IPC facilities during the mentorship visits in 20 of the 46 mentored health facilities; • renovated and partially furnished two isolation and referral facilities; • provided KSKS, Surveillance, Swab collection and transporting, SQS and other training to 3448 (75% over the target) health care workers and managers from the 78 health facilities; • provided SQS training to 100% of the health care workers (2,764) in each of the 78 health facilities; • provided IPC and other basic medical supplies to 58 of the 78 health facilities directly at least once, and in most cases more than twice, and STEP supported the CHT emergency medical depot to supply the remaining health facilities; and, • reached 2,524 direct beneficiaries through different psychosocial support services. The evaluation findings indicate that the quality of service provided by the project was consistently compliant and in adherence to MoH/WHO protocols for EVD. All protocols and procedures related to IPC were followed and were of the high standard of MOH/WHO, including hand hygiene, donning and doffing of Personal Protective Equipment (PPE), chlorine mixing for correct percentages, etc. Patient care followed MOH/WHO protocols and all required resources to run the GETU were available to provide a high standard of care. The facility was kept at a high level of cleanliness, all waste were disposed of appropriately and all medical supplies were properly maintained. There was proper segregation of red and green zones with proper precautions taken. The ETU had a constant and adequate supply of water and electricity ensuring proper cleaning and disinfections, ensuring WASH protocols were constantly observed. Patient care, including psychosocial services through mental health clinicians, was provided in a proper and timely manner. Most importantly, team work was encouraged and facilitated, and staff reported they felt supported and able to provide feedback to colleagues at all times. The qualitative survey findings suggest that STEP significantly contributed toward improved service delivery to clients at the health facilities, and its interventions positively influenced the day to day behavior of health workers. All respondents answered with a resounding “yes”, when asked whether the project had any influence on their EVD related practices. Many pointed out, that training and mentorship led to better understanding of the importance of consistent IPC practices. Health workers observed PPEs donning and doffing procedures and wearing risk￾appropriate PPEs to care for patients. Proper waste disposal practices were followed as much as possible. The mentorship activities, SQS training, and the need-based supply provision to selected health facilities was highly valued by all health care workers at all level. Respondents noted significantly improved triage and screening, case identification, waste management and hand hygiene skills. 3 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Findings from the evaluation conclude that there are several key reasons for STEP’s success: ambition from project staff, agility of the project in tracking the trend of the outbreak and making required adjustments to project priority activities based on evidence-based decision making process, and the interactive process and flexibility of the donor to accommodate anticipated needs during the no-cost extension (NCE). These factors significantly facilitated efficient use of available resources to enhance the prevention and control of EVD, to address priorities of the county health system, and, most importantly, to achieve the project objectives. Among others, the level of coordination and collaboration with the CHT, and partners like WHO, coupled with the level of STEP’s dedication, commitment, and determination to work with the national IPC taskforce, the Nimba CHT and the DHT were instrumental in exploring and addressing priority needs on time. The evaluation uncovered an inherently weak and dependent health system, ineffective community based health care, irregularities in the surveillance and preventive approaches, as well as the continued flare up of EVD and other disease outbreaks. These weaknesses challenge the advances made by the project. Interventions that can capitalize on the achievement of STEP need to exist, and the health system leadership must be supported to fully manage the system. In conclusion, the STEP project implemented all its project activities in close collaboration with the CHT/MoH and surpassed its targets, thereby significantly contributing to the prevention of EVD, and added capacity to the county health system. The close coordination with the CHT, the determination of the project management, the hard work and motivation of the staff, and guidance and flexibility from the donor, were key to project success. However, contributions are not enough to meet the level of the need the health system has to prevent and manage a potential outbreak in the future, and further efforts to strengthen and move towards a self-reliant health system are strongly recommended. 4 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 2.0 Introduction 2.1 Background Project Concern International (PCI) has been working in Liberia since 2010 to increase access to food, reduce chronic malnutrition, and increase access to improved livelihood and educational opportunities. PCI had also responded to the Ebola Virus Disease (EVD) emergency through different emergency response projects funded by USAID Office of Foreign Disaster Assistance (USAID/OFDA). As part of these response, PCI had been implementing an Ebola emergency response project, Support to Ebola Treatment Project (STEP) in Nimba County with funding from the USAID Office of Foreign Disaster Assistance (USAID/OFDA). The project started in December 2014 and initially planned to end in June 2015, but was later extended to April 2016. The project initially targeted to benefit 9,180 individuals in the area, but reached a total of 15,388 people, by the end of the project period. STEP served a catchment area of 200,000 people through community outreach, technical supports of health facilities and HCW, SQS training, and supply provision, and other capacity building interventions. The same population is also served by the health facilities (hospitals, health centers and community clinics) whose staff are trained and supervised by STEP project staff. In addition, STEP managed the Ganta Ebola Treatment Unit (GETU) in close partnership with the Liberian Ministry of Health and Social Welfare (MOHSW), and the STEP/GETU outreach team provided continuous and appropriate Ebola￾focused education, and CB-AECS at the community level as part of PCI’s Ebola-focused social mobilization and early case detection and referral effort. 2.2 Program description: The three important public health interventions aimed at any outbreak prevention and management as well as promoting health are categorized into primary, secondary and tertiary preventions. Each intervention has its focused purpose and time when it will be most important, and yet they all complement each other and have a strong synergetic effect if implemented in integration. The EVD epidemic may have been better controlled if there had been strong primary prevention interventions at household, community, and health facility levels with basic and proven preventive practices at an early stage. Had there been a strong community-based surveillance system with continuous situation analysis and response capacity, the outbreak may have been detected early enough and contained before it overwhelmed communities and an entire health system, and become a national and international public health emergency. As there was no capacity to effectively implement primary and secondary preventive public health interventions, tertiary prevention using a facility with full isolation, safe and quality treatment capacity and service, was required not only to prevent death and disability of the infected individuals, but also to isolate the suspected and confirmed cases to reduce the risk of further spread. These facilities were the Ebola Treatment Units (ETUs), like that of GETU. 5 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Therefore, together with support from USAID/OFDA, PCI implemented the STEP project. STEP was initially focused on managing and running the GETU, in close partnership with the Liberian Ministry of Health and Social Welfare (MOHSW). The goal was to slow the spread of Ebola in Nimba County through the isolation of cases, the provision of a high standard medical care, and the protection of individuals affected by Ebola at the ETU. As the result of the ambitious effort of and revelation by the project management and staff, the evidence-based decision making process, the strong partnership with the CHT/MoH and other partners in the county, and the interactive process and flexibility of the donor to understand the dynamics the outbreak, STEP was able to accommodate and address needs identified during the implementation process. Consequently, unlike similar projects in Liberia, STEP was positioned to also significantly contribute to primary and secondary preventions of EVD while still maintaining its original focus. In view of that, STEP subsequently expanded to strengthen the primary and secondary prevention of infection transmission through social mobilization in targeted communities, conducting active case surveillance at selected communities, and supporting and facilitating the integration of full EVD care to basic health service delivery system through building the capacity of the health facilities and health care workers in Nimba County. PCI’s STEP project managed both the clinical and non-clinical components of the GETU’s operations and provided multiple services, including: • provided high standard of medical care, and the psychosocial support of Ebola￾suspected cases at the GETU, and screening and isolation services at the outreach level; • conducted regular mentoring and needs-based training for health facility staff in patient care and comprehensive infection prevention and control (IPC); e.g. waste management, setting up triage and isolation, setting up PPEs procedures and practices for patient care, etc.; • provided supportive mentoring and supervision of day to day operations of the project; • supported in maintaining the highest standards of operation of the clinical services; • supplied PPEs, and other IPC and medical supplies in collaboration with the MOHSW/CHT and WHO; • supported data collection and reporting, administration of human resource functions and payment of salaries; • restored the post-outbreak basic service delivery based on the MOHSW’s newly launched SQS3 approach; • supported the Nimba CHT in epidemic preparedness and response activities; and, • coordinated the activities of the GETU with other institutions and partner agencies involved in the response including the MOHSW at the county and national levels, the National Case Management Committee, a number of sub-committees, and WHO technical advisors at the national and county levels. 3 SQS (Safe and Quality Service) is a post-EVD outbreak health service delivery protocol, and is the replacement for Keep Safe Keep Serving (KSKS) protocol that had been used during the EVD outbreak for health service delivery. 6 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Further, as part of its effort to support the Nimba CHT, STEP provided mentorship and supportive supervision to health facilities, improved health facility capacity through provision of supplies and training of health care workers, continuously provided community outreach programming to promote IPC, and conducted active EVD case surveillance in different communities along the Guinea border with a mobile team. Throughout the project life, PCI/STEP coordinated its effort with a wide range of partners in the administration of the GETU, including UNICEF and WHO, the CHT and DHT, CDC and others. A summary of partners and activities is shown in the Table 1 below. Table 1. Summary of STEP partners and coordinated activities 3.0 Evaluation Scope and Objectives STEP’s performance is evaluated by gaging results against the project plan, appraising to what extent the project objectives are achieved by analyzing the overall effect/contribution of the project on health systems strengthening and identifying gaps in the system, and revealing key lessons for future programming. More specifically, the objectives of the evaluation were to: a) explore STEP’s contribution in the EVD outbreak control and preventions using the set output/performance indicators; b) assess the level of effort in building health workers’ and health facilities’ capacity throughout Nimba County; c) determine the continued utilization/application of the skills obtained through training and mentorship; and, d) identify key lesson learned and best practices for future programing. Consequently, the evaluation aimed to answer the following key questions: • whether the STEP had achieved its target/plan; Partner(s) Coordinated Activities UNICEF and WHO Provide the supplies and medicines needed to manage suspected and confirmed EVD cases CHT Coordinate referrals and surveillance in the catchment area CDC and WHO Strengthen capacity of surrounding health facilities in infection prevention, surveillance and early case detection and referral Other international non-government partners, e.g. Global Communities and Riders for Health Transport samples to laboratories, dead body management, and in support of international border surveillance. 7 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia • whether the STEP had significant “effect/impact” in the prevention and control of EVD outbreak; • to what extent STEP contributed to stabilize, restore and improve the capacity of the health facilities and health service providers so as to prevent and control EVD and similar possible outbreaks in the catchment areas; • whether STEP’s intervention/activities had been evolving to maximize the influence and ensure sustainability of the result; • how STEP adapted programmatically in response to the trend of the Ebola outbreak and community and health system needs in the project area; and, • what best practices and lessons were learned during the course of the project and share for future programing. The primary purpose of the evaluation is to fulfil donor commitment and provide succinct information as to the outcome of the investment made to implement the project; however, the report further aims to provide donors, PCI, public health emergency professional, and other stakeholders with practical information for future decisions and actions regarding designing/planning, organizing, implementing, and monitoring similar initiatives, as well as conducting wise and continuous adjustments to maximize project resource utilization and enhance project results. Thus, users of this report include USAID/OFDA, PCI, CHT/MoH, and others. 4.0 Evaluation Methodology 4.1 Study population and data sources Nimba County, STEP’s operational area, was the focus for end-line evaluation; and the study population mainly includes county health system staff from the CHT, DHT, health facilities and the GETU4 , as well as community health facilitators or leaders. The evaluation used both primary and secondary data sources. Primary Data: primary qualitative data was collected from focus group discussions (FGDs) and key informant interviews (KIIs). KIIs were conducted with CHT, DHT, WHO, and ETU staff, health care workers from the supported health facilities, and community leaders in the outreach activity areas. Further, one FGD was held with staff who had worked at the GETU; these were clinical workers, hygienists, social workers, administration staff and others, who were asked to explore their experience and reflect lessons while working for the project, how they perceived the contribution of the project in EVD prevention and control, and how working in the project 4 The Ganta ETU had been decommissioned since January 2016, and turned into a nursing training center by G. W. Harley Nursing School, UMU – the proprietor of the property. 8 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia could have influenced their career. All assessment tools and questionnaires are provided in Annex 1. Secondary data: secondary data was collected and organized using a thorough review of key project quarter reports, the project’s Indicator Performance Tracking Table (IPTT). These sources were used to evaluate the project’s plan versus achievement, and to recapture key lessons documented over the life of the project. 4.2 Sampling and data collection methods Due to the limited number of the sample population, the evaluation used purposive sampling technique where the sample respondents were selected from the GETU, CHT and DHT, and health facility staff representing all the six districts of the county, as well as community leaders from the project target area. The GETU and CHT/DHT participants were selected to represent each of the service department, while the KII participants in the health facilities and communities were selected based on their availability, though the health facilities and communities were randomly selected. A total of 45 key informants were selected from the aforementioned lists (see Table 2). Table 2: Distribution of Key Informant Interviews Key Informant Category # Interviewed CHT, DHT and partners 5 ETU staff 13 Health Facility staff 16 Community members/leaders 11 Total 45 In addition, one FGD of seven participants, all from GETU staff representing the different areas of responsibilities/sections (1 physician assistant, 2 nurses, 2 hygienists, 1 WASH technician, and 1 ground maintenance supervisor) was used. The following table shows the distribution of key informant interview participants. Five STEP staff were selected and trained based on their competence and previous experience. Field testing was done to provide practical training and testing on the data collection tools, and was done using some ETU staff and a health worker from a nearby hospital. These field tests were not included in the evaluation KIIs and are not included in this report. STEP CoP trained the data collectors and supervisors, ensured the questionnaires were tested, and revised tools based on the test feedback. While the KIIs were held at health facilities and in the communities, the CoP facilitated the FGD and KIIs with GETU staff. The STEP CoP led the design, collection, organization and analysis of the data, and preparation of the report. The PCI Liberia M&E manager reviewed the evaluation plan, reviewed the tools, and supported in cleaning the secondary data. 9 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia All information collected was transcribed and organized. The qualitative data from the KII was organized by respondent and question, cleaned and summarized. PCI M&E manager, and PCI technical support unit, reviewed to ensure the quality of the process and outputs, including reviewing the plan, tools, helping cleaning/summarizing the qualitative data and draft reports. 4.3 Limitations of the evaluation This end-line evaluation is an internally conducted evaluation by project staff. They have better overall knowledge of the project and more familiar with the county health system and staff than an external evaluation team; however, because staff are very close to the subject matter, internal￾evaluation biases may be introduced into the evaluation. Effort was made to minimize this bias through team training and allowing them to fully dedicate their time to the evaluation process. Each step of the evaluation was monitored/reviewed by additional staff across different technical units within PCI. Another limitation is that the sample size was small and previous patients or others who received care during the project implementation could not be surveyed. However, the evaluation diversified the sample population as much as possible within the scope of the evaluation objectives and resources, to represent all levels of the health system, from county level to district, health facility and community level. Further, key partners were included as KII respondents. 10 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 5.0 Results and Interpretation: 5.1 STEP performance and contribution to EVD outbreak control and prevention 5.1.1 Review of project performance Project Targets Reached: All findings from the primary and secondary data show that the project successfully achieved its task: all project activities were completed, and, as project IPTT and quarterly reports show, surpassing most project targets. The evidence from the secondary data show that STEP directly reached 15,388 beneficiaries, a 68% increase over target. More than 200,000 people in the project catchment area were reached indirectly through the different sectors and core activities/services. Table 3 shows planned versus actual beneficiaries, broken down by project sector. Table 3: Beneficiaries targeted and reached5 Sector Beneficiaries Targeted (Planned) Beneficiaries Reached Dec 2014 – Mar 2015 Apr – Jun 2015 Jul – Sep 2015 Oct – Dec 2015 Jan – Mar 2016 Cumulative (Dec 2014 – Mar 2016) Health 9,180 687 4,715 3,597 4,366 722 14,087 Protection 355 512 434 1,075 148 2,524 Total 9,180 1,042 5,227 4,031 4,3666 7227 15,3888 The indirect beneficiaries include the population served by the health facilities (hospitals, health centers and community clinics) supported by STEP and/or served by the health care workers trained and/or mentored by STEP. Moreover, referred project records and KIIs suggested the GETU and the health facilities along the border with Guinea were also serving people from Guinea and adjacent counties, and therefore, the actual number of indirect beneficiaries could be higher than reported. There was no evidence to show documented internally displaced persons (IDPs) reached by this project. 5 FY2016 Quarter two STEP project report, Project Concern International 6 The protection sector beneficiaries were also health sector beneficiaries and, therefore, are not counted twice in this total. 7 The protection sector beneficiaries were also health sector beneficiaries and, therefore, are not counted twice in this total. 8 The protection sector beneficiaries were also health sector beneficiaries and, therefore, are not counted twice in this total. 11 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Sector Health: The objective of this sector was to provide the highest standard of medical care for Ebola patients in Nimba through the management of the GETU. Consequently, effort was made to explore three important factors: the level of service target achievement, implementation of the core components/activities, and the quality of service. The findings attest the implementation of the key planned activities as per the standard set by the MoH, and the targets had been reached (and in most cases exceeded) as outlined below. Target: Despite the low EVD caseload in Liberia, STEP consistently reached large numbers of direct beneficiaries during the project period through both facility based and community outreach, CB-AECS and screening, and ongoing clinical training and mentorship of health facility staff from across Nimba County. This enabled the project to surpass its 9,180 target, reaching 14,087 within the Health Sector (53% increase over target). Activity implemented: The appraised secondary data (reports and data sets) confirmed STEP implemented comprehensive case screening, referral, care and case management. All those services were delivered as per the Government of Liberia’s strategy to respond to the EVD epidemic, which calls for the isolation of persons with suspected, probable, or confirmed EVD both at facility (GETU) level and outreach level. The project: • supported 78 health facilities (69 primary, five secondary and four tertiary level) in Nimba County through training of their staff, mentorship, and basic IPC supply provision; • trained 3,448 (1,597 male, and 1,851 female) health care workers working in the county, which is exceeded target by 75%. 80.2% (2,764) were trained in SQS, the remaining 19.8% (684) were trained in KSKS, Surveillance, and Swab collection and transporting, and other training; • mentored 867 (428 male and 439 female) health care workers in 46 health facilities – more than double of the target; • provided consultations and clinical services to 8,865 (4,030 male and 4,835 female) people at the facility (ETU) and using outreach approaches; and, • organized 24 community events for social mobilization and outreach level services. • reached 46 of the health facilities through comprehensive IPC mentorship benefiting 867 HCW, surpassed the target by over 100%; • facilitated and supported the setup and erection of temporary triage and screening unities, waste management, and other IPC facilities during the mentorship visits in 20 of the 46 mentored health facilities; • renovated and partially furnished two isolation and referral facilities • provided IPC and other basic medical supplies to 58 of the 78 health facilities directly at least once, and in most cases more than twice, and STEP supported the CHT emergency medical depot to supply the remaining health facilities; Quality: The GETU secondary data (quarter reports, staff work schedule and attendance, and event records) suggested that the ETU staff had maintained operational readiness at all times and 12 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia the facility had been open for service 24 hours per day, 7 days per week, and the staff were working in three shifts until the clinical services were closed on October 31st 2015. This was consistent with the MOH recommendations for staffing and working schedules of ETU across the county. The reports and photos from the GETU indicated that each section and service point in the green and red zones were clearly demarcated and signposted. These included the green zone gate, staff waiting areas, donning and doffing rooms, triage and screening sites, all hand washing stations, WASH facilities in both red and green zones, the fencing and gate to the red zone, the suspected and confirmed, male and female, wet and dry symptoms, maternal and child wards were well separated, demarcated and visibly signposted. These was also physically verified during evaluation visits on April 4 and 5, 2016. All patient records were properly documented, safely placed, and the GETU submitted its daily and weekly case investigation and surveillance reports to the CHT surveillance desk, as witnessed from the report copies and record books. The project continuously monitored the quality of the documentation, regularity of reporting on individual cases, and the weekly and monthly performance reporting as noted during the focus group discussion. Facilities and operational support of the GETU: The GETU had two well maintained functional generators (165 and 150 KVA) working on alternate schedule. The facility had also two bore holes with functional submersible pumps, and six water tanks (each with 5,500 liters capacity) for water storage and well maintained and functional pipeline supplying all corners of the ETU. In addition, there were 18 hand washing stations (three at the different entry/exit points, five in the “green zone” and ten in the “red zone”). Based on available records at the GETU, the stations had been checked three times a day for presence of the appropriate hand washing supplies (water, chlorine solutions or soap) and the chlorine solutions were changed every 24 hours. All those facilities enabled the ETU to have sufficient water and steady power supply 24 hours a day throughout the week, which were a key to implement the IPC protocols consistently, and maintain WASH standard throughout the project life. The records and checklists from the hygienist section, as well as KIIs and FGD discussions, revealed that the ETU staff consistently followed the IPC and PPE protocol for patient care followed by the ETU staff. All contaminated surfaces and instruments were disinfected with chlorine solution immediately after use. Staff assigned to the suspected or confirmed ward had been visiting patients at least twice during each working shift. Every time the staff left the wards, she/he decontaminated the PPEs immediately before leaving the “red zone”. Each item was then properly disposed of, by the hygienist, at a designated location. All contaminated liquid wastes and containers were checked, disinfected and properly disposed of in a designated secure site three times in a day (every eight hours) seven days a week. The FGD and KII respondents noted that all protocols and procedures related to IPC were followed and were of the high standard of MOH/WHO, including hand hygiene, donning and doffing of PPEs, chlorine mixing for correct percentages, etc. Patient care was also provided based on MOH/WHO protocols and all resources were available to provide a high standard of care. The facility was kept at a high level of cleanliness, all waste were disposed of appropriately and all medical supplies were properly maintained. There was proper segregation of red and 13 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia green zones with proper precautions taken. The ETU had a constant and adequate supply of water and electricity ensuring proper cleaning and disinfections, ensuring WASH protocols were constantly observed. Patient care, including psychosocial services through mental health clinicians, were provided in a proper and timely manner. Most importantly, team work was encouraged and facilitated with staff feeling supported and able to provide feedback to colleagues at all times. One CHT respondent, during their KII, said, “In my opinion, the project did extremely well in its compliance and adherence to MoH/WHO protocol for EVD in the county and can be describe as excellent. This is evident by the fact that there was no incident of cross infection reported at the ETU. The ETU also had adequate supply of medical, non-medical and the resources required for IPC and for the effective running of the ETU” The respondents believed that the GETU met and exceeded the minimum standards for the safe care in the context of Ebola, as outlined in the MOH protocol. During their interviews, they attributed such performance to be a result of: • the initial training, and the continuous on-job training and mentorship given to all staff throughout the life of the project; • clear tasks and responsibilities communicated to each staff as an individual and as a team member; • availability of required supplies and materials all the time as need; • continuous access to basic facilities and equipment (including continuous power and water, washing machines, reusable PPEs, etc.) for the provision of safe care; and, • the level of monitoring and feedback process from project management. Consultations and clinical services: Based on the project historical records (reports and data set) the project provided EVD focused clinical assessments and screening to a total of 8,865 (4,030 male and 4,835 female) people through the STEP/GETU mobile surveillance team’s triage and screening as part of the CB-AECS. Of the total 8,865 consultations, only 48 (27 male and 21 female) were admitted and managed at the ETU, while the other 8,817 were screened at community level by an outreach team reaching out to different communities along the border with Guinea. Table 4 shows the sex and age distribution of all the medical consultation beneficiaries. Table 4: Number of people received clinical consultations by age, sex and consultation site Age group Beneficiaries per consultation site Total ETU Mobile CB-AECS site M F Total M F Total M F G. Total 0-11 months 0 0 0 656 608 1,264 656 608 1,264 1 – 4 years 3 0 3 1,921 1,956 3,877 1,924 1,956 3,880 5 – 14 years 3 1 4 524 592 1,116 527 593 1,120 15 – 49 years 22 19 41 630 1,200 1,830 652 1,219 1,871 50 – 60 years 0 0 0 152 243 395 152 243 395 > 60 years 0 0 0 119 216 335 119 216 335 14 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Total 28 20 48 4,002 4,815 8,817 4,030 4835 8,865 The KII respondents noted that the standard of care at the ETU was high and based on the MOH and WHO protocols for EVD care. The GETU team was trained in clinical case management and followed appropriate protocols to ensure IPC for the patients and the staff. The GETU team had a clear understanding of international protocols and procedures, they conducted live simulation drills to ensure staff was always prepared and made sure that all staff, including non-medical personnel were trained in IPC and SQS to ensure their safety and a high standard of care. One respondent from the Nimba CHT said, “One of the thematic areas of STEP, clinical management of EVD cases, was a brain child of the CHT’s own efforts to respond to the outbreak in Nimba. As such adhering to the protocol for EVD care provision, was present from the very beginning of the project. Over time and with experience, there were modifications made to address some pitfalls and improve on care provision. For example, two negative EVD PCR as criteria for discharge even in negative patients, and certification of only confirmed patients upon discharge; modification of the ETU structure to create dead spaces as a mean of enhancing IPC to protect staff and patient. The project implementation was flexible to incorporate MOH approved modifications of existing guidelines to improve overall clinical management of EVD cases” WASH and IPC protocol implementation at the ETU: The assessment findings revealed that the GETU had consistent and adequate water supply throughout, and adequate IPC supplies and materials in place for use all the time. Both the green and red zone had adequate and properly maintained functional WASH facilities (toilets, bathrooms, and handwashing stations, and functional water pipes). The WASH staff was trained on the operation and maintenance of the WASH facilities, operating the water source and pumping system, regulating the water storage and distribution, and, in collaboration with the hygienist, monitoring water flow to the different facilities within the ETU. During their KIIs, interviewees stated there was no single day that the ETU faced with shortage of water throughout the life of the project. The hygienist also was trained on: cleaning and disinfection of WASH facilities; preparation, monitoring and disposition of chlorine solutions; operating and managing the donning and doffing areas; and monitoring and refilling the hand washing stations. All types of waste were properly segregated by type and disposed; and all contaminated reusable objects, surfaces are disinfected and decontaminated. Source of medical commodities and supplies: As per the project records and documents, the ETU received adequate supplies from UNICEF, WHO, PCI in-kind donations, and PCI￾purchased from a project budget. According to project documentation, UNICEF provided all pharmaceuticals and medical supplies, and WHO donated some PPEs. The majority of the IPC supplies and commodities, including PPEs, came from an in-kind donations mobilized by PCI international office, private fund, purchased using project budget, and/or donations from other USAID/OFDA projects such as HHI (operating the Tappita ETU). All supplies and commodities were received prior to May 2015. Management and utilization of medical commodities and supplies: PCI/STEP had a proper inventory and warehouse management system, utilization and inventory reports. All appropriate warehouse house management records (stock cards, airway bill, goods receiving and dispatching 15 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia note, etc.) and reports were available monthly, in both hard and soft copies. The review of these records and documents suggested that the ETU had been using STEP commodities for its GETU facility level services, outreach services, supporting the mentored health facilities under the direction of the CHT’s supply chain management, conducting the SQS trainings, and supporting other PCI projects in IPC implementation in the workplace. There was no evidence to indicate the ETU went out of stock of any of the medical commodities and supplies throughout its operation. Furthermore, the FGD and the key informant interview (KII) respondents reported that the continuous availability of medical commodities and supplies were vital in keeping service quality to standard and consistently implement the MOH protocol for EVD treatment and care at the GETU. Based on the inventory and supply management records, PCI/STEP utilized all its stock of pharmaceuticals, medical and IPC supplies, as described above, and the monthly inventory report for March 31st, 2016 showed zero balance. Annex 4 lists the health facilities benefitting from supply distributions. Protection The objective of this sector had been to provide protection to individuals affected by the Ebola outbreak at the GETU. The number of beneficiaries targeted for this sector (9,180) was based on the number of patients projected for the GETU when the project was initially designed in 2014. A total of 48 cases were admitted to the GETU; however, while the EVD caseload at the GETU remained low, STEP extended its services to community outreach and support activities for EVD survivors and other affected persons throughout the GETU catchment area, reaching, according to project documentation, 2,524 direct beneficiaries through different psychosocial support services. The project used the MOHSW protocol for psychosocial support and child protection throughout the project life. As the project’s reports document, the project facilitated and supported the integration of 11 EVD orphans to their relatives and guardians within one week time of identification. During outreach services, the GETU’s psychosocial support team conducted community follow up visits to foster families taking care of EVD orphans. The FGD respondents confirmed that the shelter for orphans and their families, created and supported by the STEP/GETU, provided food and psychosocial support until they were reintegrated into their communities with assistance by the psychosocial team and local leaders. The STEP/ETU psychosocial team was facilitating to minimize Ebola-related stigma of affected families through counselling and community dialogue, though community outreaches, dedicating staff time to provided radio talk show and educated community member through community healing dialogue and to share the work and purpose of the ETU. Such effort helped to the integration of EVD affected families and orphans into their community within one week of identification. The project data base and reports indicated that, 4,478 people reached through social mobilization, of which 2,524 (1,112 males and 1,412 females) were targeted for special 16 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia psychosocial support and counseling focused on integrating EVD affected families and managing and supporting EVD affected children, including orphans, due to their special need.. 5.1.2 Contribution to EVD prevention and post-outbreak basic health services restoration Primarily, the project aimed to contribute to the national and global effort to prevent the spread of EVD outbreak in Nimba County, through the implementation of tertiary level clinical and psychosocial services at GETU. As the Ebola outbreak evolved, the STEP project also adjusted, addressing gaps in secondary and primary prevention of EVD. Evaluation shows that STEP visibly contributed to the overall prevention and control of EVD and to the post-outbreak restoration of basic health services, through: • supporting the CHT in sharing the burden of service delivery in terms of staff capacity building and basic health commodities and supply provision; • implementing and supporting/facilitating the implementation of the national IPC and case management protocols; • improving IPC practices at health facility and community level, stimulating and supporting the planning and operationalization of epidemic preparedness and response plan; and, • health facility capacity building. Support to the county health system: The assessment confirmed that PCI, through STEP, took over the management of the GETU when the country needed it most. The project staffs’ dedication, commitment, and willingness to work with the IPC team of Nimba CHT was instrumental in building their capacity, and was essential to building infrastructure - even temporary infrastructure - to support essential health services and rebuild the damaged health system. Throughout the KIIs, mentorship was consistently noted as being key to PCI/STEP’s success in contributing to the rebuilding of health services in the county after severely hit with the EVD outbreak. All respondents noted that they have seen a change not only in the health service capacity, but also in attitudes in themselves, their colleagues and their workforce as the result of the mentorship and trainings provided by PCI/STEP. The survey respondents noted that capacity and implementation had been enhanced, especially in IPC and SQS, through training and mentorship. They also noted that their own leadership and coordination capacity has improved as they saw increased communication, feedback and information sharing through STEP. Compliance with national protocols: The KII respondents and FGD participants ascertained that the project did extremely well in its compliance and adherence to MoH/WHO protocol for EVD in the county with many describing it as excellent. Based on the KII respondents, FGD participants, and inventory report reviews the ETU had adequate supply of medical, non-medical and the recourses required for IPC and for the effective running of the ETU, and supporting the different health facilities in the County. The CHT worked closely with PCI/STEP and the Ganta ETU team to ensure that all clinicians are making maximum use of standard case definition and 17 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia make appropriate referral; and suspected cases were isolated, attended to, investigated and referred which all were done in line with MoH/WHO protocol for EVD case management. Partnership and coordination: KII respondents from CHT and partners noted that project management remained engaged and transparent, with the door always open to the CHT throughout the implementation of the project. No challenges in regard to coordination and partnership were raised during the KIIs or FGD. Many times planning was done along with the CHT. The CHT always played the lead in monitoring and supervision with support by STEP. Feedback from the CHT was acted upon. According to project staff, the relationship was very good and commendable. Even other partners, e.g. WHO and the central Ministry, noted the strong relationship between the CHT and PCI/STEP. One district level respondent commented, “At the district level, PCI/STEP collaborated well with the DHT and shared their agenda with us, provided us transportation/ambulance support whenever needed for patient referral, and provided additional technical assistance to the DHT where there were limitation, especially during the mentoring sessions…” Strengthen IPC in the county: PCI/STEP contributed in shaping IPC practices in the county through the mentorship program, the SQS training, provision of essential medicines and medical supplies/equipment, and the setting up of temporary IPC infrastructure in different health facilities of the county. One participant said, “In my opinion, PCI/STEP was the most outstanding partner of the CHT when it came to IPC practices in Nimba. During the peak of the EVD crisis and throughout the response, PCI/STEP took the lead on establishing and maintaining the culture of IPC practices not only in the healthcare facilities, but also in the communities.” All KII respondents noted that PCI/STEP had made significant difference in the implementation IPC in Nimba County through either: • the mentorship program, • SQS training, • need-based supply provision, • setting up triage and isolation in many health facilities across the county, and/or • the renovation of two infectious disease control centers. Health facility/ Care worker capacity: Overall the KII respondents noted that mentorship program and the SQS training will make the most difference to the future of health care workers capacity building in Nimba County. The continuous training, supervision, and coaching both to the GETU staff and health care workers in health facilities across Nimba is a significant contribution to strengthen the health service delivery. One respondent said, “About 95% of PCI/STEP staff were indigenous healthcare workers posted in Nimba. All of the trainings and experiences they gathered as responders during the outbreak will remain with the county as these service providers have now returned to routine healthcare delivery. The SQS training for both public and private healthcare workers, has strongly equipped these providers to provide 18 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia safe and quality care. Each health facility (HF) also received the comprehensive SQS guideline as a reference for maintaining IPC standards in all HFs at all times.” In response to a question related to the contribution of the project’s contribution to support the health facilities, a KII respondent from the WHO office in Nimba remarked, “Capacity-building in the major areas of healthcare delivery, has been the major achievement of PCI/STEP during the project’s lifetime. Human resource capacity building will remain a major asset for the CHT as it administers healthcare delivery in Nimba. Provision of implements such as caller user groups will enhance timely reporting and isolation of suspected cases surveillance diseases in line with national protocols. Standardized healthcare infrastructure to manage epidemic diseases will greatly help to contain future outbreaks, those are some the contributions of this project.” A district health officer from Nimba also reflected on STEP’s contribution to improve services at the health facilities: “The training of health workers has improved their capacity to conduct contact tracing, investigate EVD related cases and formulate team to intervene in any emergency situation; PCI/STEP distributed assorted IPC supplied to all health facilities which have used appropriately to protect health workers, patients, and the communities from potential infections; and Temporary Triage and isolation units were built at some health facilities and helping to improve screening process.” The setting up and renovation of the temporary isolation unit (triage) at some health facilities, even though they are temporary, did help to support the knowledge and skills acquired during the training, and significantly helped to prevent and control the spread of Ebola and other infectious diseases through strengthening the screening practice. The majority of respondents (32 of the 45) noted that the strengthening of the epidemic preparedness and response capacity at the county level, especially in border districts and health facilities, and support to the roll out at the district level was a key and long-lasting achievement. The KII responses highlight the positive impact that PCI/STEP trainings have made on the capacity of Nimba County’s health system. Respondents noted that the SQS training and mentorship has significantly improved triage and screening, case identification, waste management, and hand hygiene skills in the health facilities. The KII respondents from the health facility reported that PCI/STEP supplied medical and IPC supplies and equipment, had significant contribution in implementing the IPC protocols and improve service delivery and client satisfaction. It also improved the quality of services through the in-service staff capacity strengthening (professional and auxiliary), overall facility cleanliness, improvements in all service delivery (including laboratory, delivery room, etc.). Respondents noted that the STEP had limitations in fully supporting the community based health care services. Health facility based KII respondents noted that STEP could have supported more gCHVs and strengthened linkages between the community and health facility. One respondent indicted that, “while gCHVs have a significant role to play in community based promotive and preventive health services, the engagement and support activities from STEP were limited”. Over 40% of the respondents noted that additional training was necessary for all cadres of staff at the 19 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia health facilities, especially gCHVs and TTMs. Those interviewed also emphasized the need for the creation of community structures in support of IPC (i.e. committees) and the need to expand training to all community leaders, volunteers and key stakeholders, especially traditional healers. However, this was beyond the project scope. 5.2 Effort in building health workers’ and health facilities’ capacity in Nimba County; Health Care Facilities Supported: As the evaluation shows, STEP supported all of the health facilities in the county through a combination of interventions that include mentorship, KSKS/SQS and other trainings, and supply provision. There were 78 functional health facilities in six health district in the county when STEP was operating (Annex 4 provides a cumulative list of health facilities supported by STEP during the project life). The secondary data show STEP reached 46 of the 78 health facilities through comprehensive IPC mentorship, thereby benefiting 867 HCW. STEP also facilitated the setup and erection of temporary triage and screening units, waste management, and other IPC facilities during mentorship visits to 20 of the 46 mentored health facilities. The KII and written reports show that. STEP also provided IPC and other basic medical supplies to 58 of the 78 health facilities directly at least once, and in most cases more than twice, and STEP supported the CHT emergency medical depot to supply the remaining health facilities. Respondents noted SQS training, the need based supply provision, and the mentorship to the health facility that improved triage and screening, case identification, waste management and hand hygiene skills where among the valuable contributions of STEP project. The training served as a cornerstone to build staff capacity up to standard in terms of care provision. Further, the KII findings indicated that PCI/STEP project not only significantly contributed to improved service delivery to clients at the health facilities, but its interventions positively influenced the day to day behavior of the health workers. All respondents answered with a resounding “yes” to a question on whether the project had any influence on their EVD-related practice. Many pointed out, prior to the Ebola outbreak and in the early days of the crisis, health workers were not aware/observing proper IPC practices. Now, following training and mentorship, all respondents noted that they and their teams have a better understanding of the importance of consistent IPC practices. Health workers were observing PPEs donning and doffing procedures and constantly wearing risk appropriate PPEs to care for patients; and proper waste disposal practices were followed as much as possible. Health care providers trained: The project records revealed that STEP trained 3,448 health care workers (1,597 male and 1,851 female), a 75% increase over the original planned target of 1,970. The SQS training covering 100% of the health care workers in all the health facilities (hospitals, health centers and clinics) in Nimba County, was the main reason for the over achievement. Apart from the SQS training, KSKS, EVD surveillance and response, psychosocial support, and swab sample collection were among the focus of the trainings supported by the project. Table 5 shows the training beneficiaries by profession and sex. 20 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Table 5: Training Participants by sex and Profession Professional Category Number of participants Male Female Total Medical Doctor 15 6 21 Registered Nurses 252 368 620 Physician Assistant 35 8 43 Hygienist 217 170 387 Midwifes 4 53 57 Others 1073 1247 2320 Total 1597 1,851 3,448 In response to a question related to the contribution of the project’s contribution to support the health facilities, a KII respondent from the WHO office in Nimba remarked, “Capacity-building in the major areas of healthcare delivery, has been the major achievement of PCI/STEP during the project’s lifetime. Human resource capacity building will remain a major asset for the CHT as it administers healthcare delivery in Nimba. Provision of implements such as caller user groups will enhance timely reporting and isolation of suspected cases surveillance diseases in line with national protocols. Standardized healthcare infrastructure to manage epidemic diseases will greatly help to contain future outbreaks, those are some the contributions of this project.” A district health officer from Nimba also reflected on STEP’s contribution to improve services at the health facilities: “The training of health workers has improved their capacity to conduct contact tracing, investigate EVD related cases and formulate team to intervene in any emergency situation; PCI/STEP distributed assorted IPC supplied to all health facilities which have used appropriately to protect health workers, patients, and the communities from potential infections; and Temporary Triage and isolation units were built at some health facilities and helping to improve screening process.” Considering the magnitude of training targets, effort was made to examine how successful the SQS training was. The SQS training has four levels: there are four master SQS trainers trained at national level, 43 county level facilitators trained as SQS facilitators by the master trainers, and 472 clinical level and 2,247 non-clinical level HCWs trained. Pre and post training test results from randomly selected health facilities were documented in the training databases, and these were compared. Further, reflections from key informant interviews regarding trainings were also collected. 21 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia The pre and post-test score comparison showed an average of 37 (64.5%) points gain in IPC, PSS, clinical practice knowledge among clinicians, and an average of 32 point (52.4%) increase in IPC practice knowledge among non-clinicians9 . Although the passing point was 60%, as per the WHO/MOH set criterion, all four of the master SQS trainers 84% (36 of 43) of the county level SQS training facilitators, 99% (469 of 472) of the clinical HCW, and 96% (2152 of 2247) scored above 70% in the final test, highlighting the success of the SQS training. .. There were no drop outs in any category. Based on the KII participants’ reflections, the SQS training was among the most valued contribution of the project in strengthening the capacity of the health workers. Nearly all of the respondents from the health facilities reflected that the SQS training brought about several changes in the quality of health care services at health facilities and service provider confidence in case management and IPC. Improved knowledge and practice of IPC, through SQS trainings, was noted as a very important intervention at health care facilities. It was reported that these trainings, coupled with supplies of equipment and medicines, increased health care workers’ capacity in risk assessment to identify emergency, priority and queue patients, improved sanitation and hygiene practices, and improved screening and case identification. Respondents noted that facilities were better organized and cleaner from improved waste management. In addition, respondents noted that creating temporary triage/screening areas in combination with the SQS trainings improved isolation of suspect cases. For example, one respondent noted that, SQS training complemented by the preceding mentorship “practically demonstrates to us why every patient that comes to the clinic must enter through triage so that they are correctly screening for suspicious symptoms, and how and why a risk appropriate PPE should be utilized.” Another respondent commented that the SQS training was helpful to the way it enabled them to better communicate with patients,noting that it “helped improved our way of talking to a patient in a manner that makes them feel relaxed and comfortable.” Given the fear surrounding Ebola, this is an interesting remark regarding the benefit of the training. The trainings appear to be fundamentally important component of the success of the intervention. As one respondent noted, the trainings “enlighten our minds on how to provide care to our patients.” Mentorship: STEP, in collaboration with CHT and WHO, engaged in the mentorship of high priority health facilities in Nimba County. The purpose of the mentorship was to support the targeted health facilities overall system to implement the national IPC minimum standard in the context of EVD, and train and mentor the health care workers in those health facilities to comply and implement the IPC universal precautions and the Liberian IPC minimum standard in the context of EVD. Initially, the mentorship was started based on the then “Keep Safe Keep Serving,” or KSKS, protocol, and later shifted to the Safe and Quality health Services (SQS) protocol10 few months after Liberia was first declared Ebola free. 9 The point gain/loss is calculated by subtracting the pre-test result from the post-test result. 10 KSKS and SQS are both MOHSW standard protocols for IPC. KSKS protocol had been used to implement IPC intervention in the context of the EVD outbreak; now that the outbreak is under control, KSKS protocol was replaced with SQS during the reporting period. 22 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia The project records show that STEP covered 46 of the 64 mentored health facilities, above the target of 24 health facilities, which were initially targeted high priority health facilities. This coverage included mentoring on regular hand washing and hygiene practices, setting up and implementing triage and screening procedures, appropriate use and disposal of PPEs (including donning and doffing procedures), health facility waste management and environmental cleaning, and IPC supply chain management, were among the areas covered in each of the mentorship visits. As part of the mentorship, the mentors also supported the health staff in some of the facilities, to set up and rehabilitate temporary triage structures, established hand washing stations through providing staff time and supplies (e.g. buckets and forceps, chlorine solutions, etc.). The project staff mentored more than double the health care workers (324) originally targeted. The project records show that 867 (428 male and 439 female) health care providers in 46 health facilities were mentored over the life of the project (See Table 6). Table 6: Health Facilities and Health Care Workers Mentored by STEP Type Facility Mentored Quantity Health Care Workers mentored11 Clinician Non-clinician Total Grand Total Male Female Male Female Male Female Hospitals 5 49 78 55 48 104 126 230 Health Centers 2 13 15 37 38 50 53 103 Clinics 39 54 62 220 198 274 260 534 Total 46 116 155 312 284 428 439 867 The qualitative data gathered from KIIs noted mentorship as among the most important activities that facilitated IPC practices and improved capacity and confidence of the health care workers. The findings demonstrated that the mentorship component of STEP’s outreach program helped build the technical knowledge and proficiency of health workers and strengthened IPC implementations in Nimba County. An officer in charge in one health facility in Tappita district, said, “PCI/STEP did especially very well in making hand washing practices are effective and consistent; screening of patients, visitors and staff before entering health facility; improved screening and isolation through building of temporary triage; and setup procedures to use PPEs, and improve the waste disposal and management in our facility – all as a the result of the conducted mentorship program at our clinic….” The respondents also noted that the mentorship activities improved health care workers’ knowledge on prevention, assessment, case management, and met overall goal of behavior modification. It helped the service providers by making them aware of important routine practices such as on the need for hand hygiene, and their social behaviors including hand shaking, hugging etc. 11 According to the CHT/MOH, Clinician HCW include: MDs, Physician Assistants, Nurses, and Clinical Midwifes; and Non￾clinician HCW includes, hygienists, nurse aides, dispensers, vaccinators, cleaners, TTMs, and others. 23 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia According to the KII respondents, the mentorship also helped them learn how to engage with community-based health volunteers to support the health facilities in creating a safer environment. Mentorship helped increase active participation by gCHVs and community leaders to improve IPC infrastructure (fencing, waste disposal, and maintaining water points) of health facilities. Mentorship also brought improvement in community dead body management through health education and community awareness promotion. Mentorship contributed to the improvement of all aspects of IPC and health facility management. It also improved the quality of services through the building of staff capacity (professional and auxiliary), overall facility cleanliness, improvements in all service delivery (including laboratory, delivery room, etc.). A medical director of one of the hospitals in Nimba County reflected, “PCI/STEP conducted mentorship and 15-20 staff were mentored on IPC protocol; conducted SQS training that increased the knowledge capacity of all our staff in IPC practice, waste management and hand hygiene, case management; and taught us the KSKS approach to IPC practice, which is now replaced by SQS approach, and provided us IPC supplies – all these supports were very helpful to improve service quality” A staff member at the health facility in Zoe-geh district said, “First, we never have knowledge on triage screening, hand hygiene, or IPC in general, but we acquired adequate knowledge on IPC protocol, waste management, and hand washing through the intervention of PCI/STEP. In addition, PCI/STEP brought positive changes to our patient care by sending mentor to refresh our knowledge and practice.” 5.3 Continued utilization/application of the skills obtained through training and mentorship The key informant interview respondents pointed out that the mentorship activities positively impacted on their basic skills and knowledge, including the preparation of appropriate chlorine solutions, the disinfection of medical instruments and reusable PPEs, proper waste management, and how to clean environment in a manner to promote health. Key informants noted that hygiene practices are improved: hand washing stations are seen everywhere and patients and visitors are making use of such facilities to protect themselves. They also stated that patients and visitors are properly screened before entering health facilities. According to interviewees, trainings helped them as a key reminder to implement the IPC protocol and refresh on some basic skills on IPC and case management, which they had forgotten. The respondents also said that the mentorship has led to improved hand hygiene practices and the importance of consistent placement of hand washing stations at the health facility; proper patients and visitors screening before entering health facility; case separation and isolation, and organize the setup of the health facility to better implement the IPC protocol, including organizing the OPD area, the laboratory, in-patient service, donning and doffing areas, waste segregation and disposal, as well as fencing of the health facility. Over 80% of the KII respondents and the FGD participants noted that, as the result of the STEP training and mentorship, they would now prepare chlorine solutions properly and know how to disinfect areas of possible contamination. They also noted that they would have more confidence 24 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia in caring for their patients appropriately, including triage and isolation. Waste management practices are essential to the prevention of infection and a majority of respondents noted that they have good knowledge of the importance of IPC and waste management. One staff in one of the health facilities in Gbarlay-Geh district, said, “Generally, the mentorship helped put things in order, for instance, the laboratory section was disorganized, waste was poorly managed and poorly disposed, and staff were not following IPC protocol, but the mentorship improved the system of waste segregation and management; it helped to clean and organize the laboratory working environmental, and the condition of the health facility. The mentorship also created room for gCHVs and community people involvement in health facility work thereby linked the gCHVs and community in improving health activities. Further, mentorship brought improvement in community dead body management by promoting health education and community awareness.” Further, the health workers noted that the continued supply of the IPC and medical commodities helped them in demonstrating the appropriate IPC practices. One health facility staff from Saclepea district said, “PCI/STEP supplied essential drugs, IPC supplies, patient bed, and other assorted medical supplies when we were really in need of them. Those support, not only will keep us safe and work in safe environment, but were very helpful to provide the routine health care services and to practically implement what we have gained during the trainings with confidence and without fear.” Another KII respondent said, “Due to the lack of IPC supplies at the health facility I am working, before, health workers in my facilities were not protected, but PCI/STEP provided those personal protective materials, chlorine, and other IPC materials; and trained us how and when to use them that improved our knowledge and skill in patient care and use of protective measures. As the result, I am set to serve in a very safe environment and highly motivated to do my job.” 5.4 Key lessons learned for future programming • The aspiration and vision by the project management and staff, the flexibility of the project, the evidence-based decision making process, short decision-making path that PCI had, as well as the interactive process and flexibility of the donor to understand the dynamics the outbreak and accommodate needs identified during the NCE, had significantly helped the project to efficiently utilize available resources so as to speed up implementation of all project components, enhance its contribution to the prevention and control of EVD, addressed priority needs of the health system in the county, and, most importantly, to achieve the project objectives. Besides, as well noted by the key informants, due to the improved communication and feedback system, STEP facilitated joint planning exercises, and information sharing, thus improving leadership and coordination capacity of the key stakeholders at the county, especially the CHT. 25 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia • The level of coordination and collaboration with the CHT, and partners like WHO, significantly contributed to the success of the project. The effective engagement of PCI/STEP’s staff to work with the national IPC taskforce, the CHT and the DHT of Nimba was instrumental in exploring and addressing priority needs on time, and had significantly contributed to improve the county’s health system. • Having a locally staffed ETU significantly improved STEP’s ability to work closely with the communities and the CHT/MOHSW. Further, 80% of staff who transitioned from the GETU at the end of the project are now working in the different health facilities in the county, a continuing asset to the health system. • The series of flare ups of EVD cases in Liberia after the country was declared free of EVD is an important indication and continued reminder to maintain high levels of vigilance to monitor the situation, examine trends, and intensify surveillance and social mobilization on IPC, and most importantly, for functional and robust community based health care. • Mentorship was consistently noted as being key to PCI/STEP’s success. Mentorship and the SQS training were most valued by all respondents, and all noted that those two components has well-appointed the HCWs in the county, with basic knowledge about patient care, hand washing practice, risk assessment, psychosocial services, set-up and use of triage and isolation facilities, and appropriate waste management, and use of risk appropriate PPEs. In addition, the respondents from the health facilities, noted the continuous provision of IPC and medical supplies had helped them to improve health services, and apply what they had learnt from the trainings and mentorship. • The KII respondents strongly agreed that PCI/STEP interventions had significant influence in their day to day practice of IPC. They noted that “Prior to the Ebola outbreak, and in the early days of the crisis, health worker were not aware of or observing proper IPC. Following training and mentorship, now all respondents noted that they and their teams have a better understand of the importance of consistent IPC. Health workers are adhering to PPEs donning and doffing procedures and constantly wearing risk-appropriate PPEs to care for patients; and proper waste disposal practices are being followed at much as it need to be” • Maintaining and strengthening relationships with all key stakeholders (schools and community based organizations; community, traditional, governmental and religious leaders; EVD survivors; and community health clinics) was an essential part of the effectiveness of STEP activities. These relationships can and must be maintained and replicated to build strong epidemic preparedness and response systems across the board through existing social and behavior change approaches, strengthening existing surveillance capacity, creating/improving community-facility linkages, and building community resilience. • Despite mentorship and supervision activities, in 50% of the facilities technical assistance was challenged by a lack of or irregular supply of IPC supplies and consumables and poor infrastructure. Most respondents highlighted the severe infrastructure limitations of health facilities in the county as key challenges to consistently implementing the national IPC 26 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia minimum standards. Consequently, the respondents wished PCI/STEP would have built permanent incinerators, instead of simple renovations and putting zinc over damaged ones; requested construction of permanent triage and isolation areas, which was unallowable by the grant, would have been very important for health system rebuilding and strengthening. • Based on survey findings and observation, while gCHVs have a significant role to play in community based promotive and preventive health services, the engagement and support activities from STEP were limited. All respondents noted that additional training was necessary for all cadres of staff at the health facilities, especially gCHVs and TTMs. • The respondent also emphasized the need for the creation of community structures in support of IPC (i.e. committees) and the need to expand training to all community leaders, volunteers and key stakeholders, especially traditional healers. • As the PCI/STEP closes, many respondents noted maintaining the level and scale of mentorship and on-site capacity building activities at all health facilities as an imminent gap. The survey participants noted that there was a will continue to be a need for continued mentorship and integrated supervision on SQS and a constant supply of IPC materials in all health facilities. • Due to the emergency nature of the project, very short contracts (up to three months at a time) led to stress and uncertainty for most STEP staff. Additionally, lack of compensation for overtime work, sudden shifting to different responsibilities after the cessation of clinical services at the ETU, inconsistent and ineffective medical insurance, unsuccessful treatment outcomes for some patients, and finally, witnessing the decommissioning of the ETU when it could be used as a an infectious disease control center, were the most disappointing/low points as reflected by the project staff. 27 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 6.0 Conclusions and Ways forward 6.1 Conclusions In conclusion, STEP project not only achieved and/or surpassed its targets, but also became a great opportunity to further continue health system strengthening in Nimba County. STEP implemented all its planned activities and performed well in achieving all its targets. All evidence suggests that STEP project, through the implementation of IPC promotion and demonstration at community and health facility levels, effectively supported surveillance activities, established effective triaging/screening and isolation protocols and facilities for suspected and confirmed cases, and improved the technical capacity of health workers through training and mentorship. These outcomes played a pivotal role in the EVD prevention and control efforts. The provision of need-based IPC and other medical supplies support to selected health facilities, coupled with health care worker capacity strengthening, contributed to restoring basic health services post-outbreak, while strengthening the capacity of health facilities to prevent and contain a possible flare ups of EVD and/or other disease of outbreak potential. Improved technical capacity of health workers, including staff working at the GETU, that resulted from the different trainings and mentoring sessions conducted by STEP, became a major asset to the county in terms of health system capacity. These capacities have been pivotal in current efforts to develop epidemic preparedness and response efforts in the county, and in restoring post outbreak basic health services, improving the quality of health services, and building communities’ trust on the health system that had been lost during the outbreak. STEP project’s capacity strengthening interventions significantly improved the day to day IPC practices of thousands of health workers in Nimba. This training and mentorship helped health workers to better understand the importance of consistent IPC and to put that knowledge directly to practice. During supervision and mentoring visits, health workers were consistently observed properly and constantly wearing risk appropriate PPEs, practicing PPE donning and doffing procedures, and regularly applying/following proper waste disposal practices/procedures. An important element of success for STEP was the effective, consistent and ongoing coordination and collaboration with the CHT and DHT, partners like WHO, and the national IPC taskforce. Such coordination was instrumental to identify and address priority needs on time, improving the county’s health system. Additional elements that contributed to the project’s success include the commitment and motivation from project management and staff, the agility of the project to identify and adapt to evolving circumstances, the evidence-based decision making process implemented for technical and operational decisions, as well as the flexibility of the donor to accommodate new requests that resulted from emerging needs identified during the NCE. All these significantly facilitated the efficient utilization of available resources, thus enhancing the project’s contributions to the prevention and control of EVD, while responding to priority needs of the county’s health system, and, most importantly, achieving project objectives. 28 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Furthermore, STEP helped to improve leadership and coordination capacity of key stakeholders at the county, especially the CHT, through the effective and continuous communication which included a swift feedback system, facilitation of joint planning exercises, and regular information sharing activities. 6.2 Way forward An inherently weak and dependent health system, ineffective community based health care, irregularities in the surveillance and preventive approaches, as well as the continued flare up of EVD and other disease outbreaks, will challenge progress made by the STEP project unless additional interventions are implemented to capitalize on its achievements. The following recommendations are made: • Unless the health system has determined and functional leadership, that fully owns and leads at all levels of the system - and becomes fully accountable to its challenges, gains, and problems - maintaining or replicating positive lessons and good practices is always impossible. • Epidemic preparedness and response should be further strengthened by having clear mandates and shared responsibilities and accountabilities among the key players. The series of flare up of EVD cases in Liberia and its neighboring two countries, after they had been declared Ebola free, serve as an important reminder of the need to ensure and maintain appropriate systems in place to monitor the situation, examine trends, and intensify surveillance and social mobilization on IPC, and most importantly, the strong need for functional and robust community based health care that includes surveillance. • Training is an important component of capacity and health systems strengthening, as it provides participants with an opportunity to gain knowledge, skills and an incentives to implement a given task in a given setting. However, training by itself is not an end result, and it has to be complemented by supportive, effective, on site and regular mentorship. The lesson from this project is very clear in that mentorship was consistently noted as being key to PCI/STEP’s success and the most highly valued element by health workers as a means of building their capacity and source of motivation. As the PCI/STEP closes, many stakeholders, from the county and district health team and health facilities, noted continued mentorship as an imminent gap to be addressed in the near future. Thus, though resource intensive, mentorship and a post-training supervision, should be prioritized as key interventions to uplift and improve the human resource capacity in Nimba, and in Liberia in general. • As part of the community based health care system, maintaining and strengthening relationships with all community level stakeholders (schools and community based organizations; community traditional, governmental and religious leaders; EVD survivors; and community health clinics) will continue to be an essential part of an effective emergency 29 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia preparedness/response system. Using Social and Behavior Change approaches like the ones implemented by STEP, will help build upon surveillance capacity created by STEP and will contribute to building community resilience. • As a key component of the health system, functional and robust supply chain management (SCM) is very crucial. Lack or weak SCM counteracts the positive effects of any technical assistance and other capacity strengthening achieved and will continue to undermine the system’s ability to implement recently acquired technical capacity and motivation. Thus, efficient supply management system is another area that will continue to require the support and attention of health system leaders. Finally, it is certain that ‘health is made at home and fixed at the health facilities.’ This is more accurate for resource-limited communities and nations like Liberia, where a strong community￾based health care system, can be an efficient alternative to help prevent and address most of the health challenges in the country. At the heart of community-based health care is active and meaningful community engagement by its volunteers: gCHVs, TTMs, community health service supervisors, traditional healers, and community leaders. These community representatives would not only serve as change agents for better health and disease prevention at household and community levels, but would also act as bridges between the community and facility services, and would advocate for specific improvements needed. This component of the health system is crucial in helping minimize or prevent future potential outbreaks, while effectively promoting better health at household and community level. 30 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Annexes Annex 1: Survey tools and questionnaires A1.1 STEP End-line Evaluation Key Informant Interview Guide Definition and Purpose: Key informant interviews are qualitative in-depth, one-on-one interviews with people who have first-hand knowledge about their offices or health facilities or community, its staffing, and issues related to the different activities that PCI/STEP are implementing and trying to investigate. This interviews aims to understand the understanding, perception, and values of the different interventions that PCI/STEP has been implementing in Nimba County, in general and in their particular district, health facility and/or community specifically. Therefore, the interview must be conducted based on the guiding points and instructions outlined below. A. Instructions to the Interviewer: 1) Introduce yourself. 2) Establish the purpose for the interview. 3) Explain why his/her cooperation is important in collecting the information you need. 4) Explain what will happen with the collected information and how the community will benefit. 5) Ask the informant if they have any questions before you begin. 6) Ask the questions on the key informant interview guide, and where needed probe to learn additional information. 7) When give unclear answers, the interviewer should probe for fuller, clearer responses. 8) A few suggested techniques are: repeat the question, explain that you have limited understanding of the subject and ask for specific detail, or repeat the participant’s reply. 9) Summarize main points from the interview. 10) Provide an opportunity for the key informant to give any additional information or co B. Instructions to the Note taker: 1) Record major themes, ideas, comments and observations. 2) Use KII Note Taking Form. 3) Document verbal and non-verbal communication. 4) When in doubt, don’t leave it out! 5) Do not throw away any papers with notes of the interview. 6) After completing the interview please review your notes for completeness before leaving the venue. 7) In evening, interviewer and note taker should review and consolidate notes to ensure complete documentation. 8) Capture any new insights that emerged as a result of this discussion with the interviewers. 9) Save all notes from FGDs C. Interviewer/Note taker Information: Name and signature of Interviewer: ____________________________________________ 31 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Name and signature of Note taker: _____________________________________________ District: _____________________ Health facility/community: _____________________________ Date: ________________Time: ________ D. Interviewee Information: As filled in the questionnaire (Optional) Name: ________________________ Sex: ________________, Position/profession: ______________________ E. Introduction (Interviewer): Hi my name is ______ (interviewer), and this is my colleague, ______ (note taker), and we work with the _______. Thank you for sharing your time with us today. Before we begin, we need to inform you of several things. The purpose of today’s group discussion is to gather feedback about your experience with the work of PCI/STEP that manages the Ganta ETU. Sharing your experiences and opinions will help us document the lessons and improve our future similar interventions, so we would like you to be honest and open with your responses. We do greatly value your participation, but also need to let you know that your participation in this discussion is completely voluntary. You are not required to be here as to participate in this group discussion. By participating in this discussion you are consenting to allow us to use your anonymous responses to help inform program planning in the future. I am going to ask you some questions about contribution of STEP/Ganta ETU, and my colleague (note taker) is going to take notes on our conversation. Your privacy is very important to us, and your name will not be linked to anything that you share with us today. We also request that you respect the privacy of others in the room and not share their comments outside of this group. We anticipate this discussion to last for 1 hour. Please be patient and participate in the discussion through its entirety. Your views and opinions are valuable to us. Remember that this is an open discussion and I would like you to share your views freely. If you are no comfortable in taking part in this you are free to say so. Please note that your refusal to take part in this will not be held against you in any of your interactions with PCI. At this point, the interviewer asks whether the participants will take part in the interview. If yes, the interviewer continues. If not, the interviewer thanks the participant and excuses the participant from the interview. Note to Interviewer: Instructions and probes for interviewers are bolded throughout the guide Question 1: Question 2: Etc…continue Exit: 32 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Thank you again for you time today. Your comments will help us to better understand how __________, and how we can improve future programs. Please remember that we will keep the information you provided anonymous, and we ask that you not share other participant’s responses. A1.2 STEP End-line evaluation Key Informant Interview Questionnaire A. Introduction to the Questionnaire (this is to all questionnaires categories) STEP Project has been managing the MOHSW-staffed Ebola Treatment Unit (ETU) in Ganta in order to slow the spread of Ebola in Nimba County through the isolation of cases, the provision of a high standard of medical care, the protection of individuals at the ETU affected by the Ebola outbreak, strengthen the primary prevention of infection transmission in Nimba County, and support and facilitate the integration of full EVD care to basic health service delivery system. Though the primary focus of the project was to manage the tertiary referral center for EVD suspected and confirmed cases at GETU, STEP also leverages the skills and resources of the GETU and its staff to support ongoing outreach programs to communities and health facilities in throughout Nimba County. Thus, this exercises is aimed at looking at the performance of PCI/STEP over the last 15 months period, and document lesson and stakeholder reflection in the overall process and achievement of the project. The major strategic approaches that have been used to achieve STEP’s project objective have been:  Providing high quality/standard medical care to admitted EVD suspected and confirmed cases at the Ganta ETU, based on the MoH protocol for EVD care;  Providing psychosocial support and protection to individuals affected by the Ebola outbreak at the ETU ;  Conduct focused primary and secondary EVD prevention interventions at community level, that includes social mobilization and active case surveillance;  Strengthen the capacity of health facilities and health care workers to implement EVD focused and MoH minimum standard for infection prevention and control; Based on this, it is important to get reflection from different stakeholders on the implementation process and results achieved. This helps PCI to learn and document the process of implementing the project, and take a lesson on what improvements must be considered while designing and/or implementing future public health or development projects. Accordingly, PCI/STEP highly values your input and appreciates your contribution in outlining your thoughts on the issues below. B. ETU Staff Name: _______________ (optional) Organization: ____________________ 1. As PCI/STEP employee, what do you value most while working for STEP project? 2. Do you realize any change of attitude or understanding about EVD on yourself that as a result of direct involvement as a staff of the Ganta ETU? What are these changes you realized? 3. How do you describe your contribution in providing high quality/standard medical care to admitted EVD suspected and confirmed cases at the Ganta ETU, based on the MoH protocol for EVD care; 4. How do you justify if the medical services being provided to EVD suspected and confirmed cases at the Ganta ETU, were high/standard quality and were consistent to the MoH protocol for EVD care? 33 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 5. What was you direct contribution to maintain the quality of services to be high standard and quality services and as per the MoH protocol for EVD care; 6. You are among the health care workers running a high/standard quality medical care to EVD suspected and confirmed cases at the Ganta ETU. How would such experience influence/shape your future professional career? 7. What do you consider some of the most significant trends, events, and developments shaping the IPC practice in Nimba County you believe STEP has contributed to? 8. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to the future of health care workers capacity building in Nimba County? 9. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to strengthening the IPC implementation in Nimba County? 10. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to strengthening the epidemic preparedness and response capacity of the county level health system in Nimba County? 11. What has been your major learning, insight, or discovery so far while working in the STEP project? 12. As an engaged professional, there are inevitably high points and low points, successes and frustrations. What stands out for you as a high point when you were part of an outstanding STEP/Ganta ETU team member? a. What has been a high point of your involvement with STEP? Why was it a high point? b. What do you especially value: i. About STEP as a project that adds value to EVD prevention and control project implementation? ii. About STEP, a key contributor to restore the basic health services through building the capacity of health facilities in Nimba County? iii. About STEP, as a key contributor/player to restore the basic health services through building the capacity of health care workers in Nimba County? iv. About STEP, as a key contributor/player to improve the infection prevention and control practices in Nimba County? 13. How do you think your experience and learning while working for STEP/PCI would shape your professional career, and enhance your contribution to the county health system or beyond? 14. What could PCI/STEP have done more to further boost its achievements and address areas which otherwise were not addressed during the course of the project? In terms of a. Health facility capacity? b. Health care workers capacity? c. IPC implementation? d. Community facility linkage to improve IPC? e. Others? 15. How do you think PCI/STEP could have achieved more or addressed these gaps? 16. What are the areas where you feel more projects like STEP engagement could have the most impact on improving IPC and Epidemic preparedness and response in Nimba County? C. CHT, DHT, Partners Name: _______________ (optional) Organization: ____________________ 1. As a key partner of PCI/STEP, what do you value most while partnering with STEP project to manage the ETU, jointly work on mentorship and all other efforts to improve the IPC practice in the county? 2. Do you realize any change of attitude or understanding on effective partnership on yourself and your office as a result of direct involvement with STEP project staff? What are these changes you realized? 3. In your observation, how do you describe the compliancy of the project to MoH/WHO protocol for EVD care, while providing high quality/standard medical care to admitted EVD suspected and confirmed cases at the Ganta ETU? 4. How open was the project management for partnership, receiving monitoring and supervision feedbacks from your office, in improving or maintaining the quality of services to the standard and quality services of the MoH protocol for EVD care? 34 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia 5. What do you consider some of the most significant trends, events, and developments shaping the IPC practice in Nimba County you believe PCI/STEP has contributed to? 6. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to strengthening the IPC implementation in Nimba County? 7. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to the future of health care workers capacity building in Nimba County? 8. What do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to strengthening the epidemic preparedness and response capacity of the county level health system in Nimba County? 9. What could PCI/STEP have done more to further boost its achievements and address areas which otherwise were not addressed during the course of the project? In terms of a. Health facility capacity? b. Health care workers capacity? c. IPC implementation? d. Community facility linkage to improve IPC? e. Others? 10. How do you think PCI/STEP could have achieved more or addressed these gaps? 11. What are the areas where you feel more projects like STEP engagement could have the most impact on improving IPC and Epidemic preparedness and response in Nimba County? 12. Any additional suggestions comments you would like to provide to PCI?STEP __________________________________________________________________________ Thank you for your time and contributions D. Health Facility Name: __________________________ (optional) Facility: ____________________ 1. If you know PCI/STEP project that manages Ganta ETU, what interventions or in puts does the project have had in your facility or the health care workers in your health facility in the last one year? 2. From all the inputs/interventions PCI/STEP have had in your facility, which one(s) do you value most? And why? 3. Do you realize any change of understanding about EVD, EVD management and importance of IPC on yourself, as a result of the support from staff from PCI/STEP? What are these changes you realized? 4. How do you describe the contribution of the PCI/STEP support in improving the quality of service and implementation of IPC protocols in the health facility you are working? 5. If you were mentored by PCI/STEP staff, how does that mentorship helped you in improving your capacity to better carry out your responsibility as a health care provider? 6. What was the direct contribution of the mentorship activity to improve the quality of health care services in your health facility? 7. If you were trained on SQS by PCI/STEP staff, how does that training helped you in improving your capacity to better carry out your responsibility as a health care provider? 8. What was the direct contribution of the SQS training in improving the quality of health care services in your health facility? 9. What could PCI/STEP have done more to further increase its achievements and address areas which otherwise were not addressed during the course of the project? In terms of a) Health facility capacity? b) Health care workers capacity? c) IPC implementation? d) Community facility linkage to improve IPC? 35 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia e) Others? 10. How do you think PCI/STEP could have achieved more or addressed these gaps? 11. How do you think PCI/STEP could have achieved more or addressed these gaps? 12. Any additional suggestions comments you would like to provide to PCI?STEP __________________________________________________________________________ Thank you for your time and contributions E. Community members or/and leaders Name: __________________________ (optional) Community: ____________________ 1. If you know Ganta ETU, and if any staff member from the ETU ever had visited your community, what had they done during that visit to your community? 2. What was the different services the health workers from ETU had been providing to your community? 3. How helpful was the Ebola screening services that the ETU staff had been providing to your community? 4. How helpful was the education on prevention of Ebola that the ETU staff had been providing to your community? 5. From all the inputs/interventions that the ETU staff had had in your community, which one(s) do you value most? And why? 6. What could ETU staff have done more to further increase their support/help to your community in the prevention of Ebola and other diseases and address areas which otherwise were not addressed during the course of the project? 7. How do you think the ETU staff could have helped the community in the prevention of Ebola and other diseases or addressed these gaps? 8. Any additional suggestions comments you would like to provide to PCI?STEP __________________________________________________________________________ Thank you for your time and contributions 36 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia A1.3 STEP End-line Evaluation FGD Guide STEP End-line Evaluation Notes for Planning, Conducting, and analyzing FGD findings/outcomes March 12, 2016 A. Planning: a) Staffing: The focus group will have one facilitator/interviewer, who will guide the discussion, and one1 note-taker (and translator, if necessary). At the end of the session, the facilitator/interviewer and the note-taker should debrief in order to ensure that the main themes of the conversation were captured. b) Participants: The focus group is conducted with 6-8 members of the ETU who make up the clinical group, and all have similar characteristics. These members are likely to be participative and reflective. c) Scheduling: The focus group discussion will be done on the dates between March 25th and 30th, and is planned to last about two hours. d) Setting: The focus groups is going to be organized in the staff training room of the then ETU, where participants are well familiar with and hoped to feel comfortable sharing their experiences. The seating will be arranged or configured in such a way that all members can see each other. B. Essentials of the FGD process – the following basic actions guides will be ensured before, during and after the FGD: a) A skilled facilitator/interviewer will remain neutral both in speaking tone and body. b) Ask open-ended questions and being careful not to lead participants to particular answer. c) Welcome: Welcome and thank the participants for sharing their time. d) Introductions: The facilitator/interviewer should introduce him/herself and the note-taker. The facilitator/interviewer should allow the participants to introduce themselves. e) Set the stage: Review the objective of the focus group. Explain how the information will be used and shared. Since the session is often a one-time occurrence, it's useful to have a few, short ground rules to encourage participation: 1) there are no right or wrong answers, 2) everyone’s opinion is valued, and 3) we are interested in what was discussed in the session, not WHO said what. f) Note Taking: Explain how the session will be recorded (e.g., notes). g) Focus group guide/Interviews and probes: Ask questions on the focus group/interview guide, and where needed probe to learn additional information. When participants give unclear answers, the facilitator/interviewer should probe for fuller, clearer responses. A few suggested techniques are: repeat the question, explain that you have limited understanding of a subject and ask for specific details, or repeat the participant’s reply. h) Participation: Ensure even participation among the group, particularly in cases where one or two people are dominating the conversation. i) Conclusion: Conclude the focus group/interview by thanking the participants for sharing their perspectives, and ask if they have any additional questions. C. Guiding Principles during the FGD: a) Only one person talks at a time b) Assure confidentiality—”What is shared during FGD should not be shared outside FGD” c) Important to hear everyone’s ideas and opinions 37 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia d) Important to hear all sides—positive and negative—of issues e) Important for men’s and women’s ideas to be represented equally D. Facilitation – the following facilitation values will be warranted during the FGD: a. Active listening i. Listen carefully and probe based on responses ii. Note nonverbal cues and behavior and respond accordingly iii. Look at participants when speaking b. Maintain neutrality c. Allow silence at times—can encourage elaboration d. Encourage discussion, not consensus e. Use probes (open-ended questions): i. “Please tell me more about…” ii. “Please explain what you mean by…” f. Avoid interrupting respondents as much as possible g. Use probes to clarify information h. Avoid making assumptions—clarify with simple questions i. Avoid leading respondents j. Watch your time! Note: When: a. Someone Dominates i. Acknowledge contributions: “I really appreciate your comments” ii. Look directly at rest of group and note “I am interested in learning what other persons think of this issue” iii. Directly ask other group members “What do the other group members think about this issue/that comment?” b. When Women and Men Participate at Different Levels i. Use same techniques as in previous slide ii. Directly ask women what they think c. No One Responds i. Ask question in a different way ii. If topic seems sensitive, move to a less sensitive topic and attempt to bring up more sensitive topic later in discussion iii. If participants say they are uncomfortable with topic, thank them and do not bring it up again iv. If group appears to have exhausted an issue, ask if there are any additional comments and move on d. The Group/Interview is Off Topic i. Steer group back to main topic, such as “Thank you for that interesting idea. It sounds like something that could be explored at a separate time. For the purposes of exploring the specific topics of this discussion, I would like to move on to the next question.” ii. Provide a time check. e. Side Conversations i. Stress in ground rules—only one person speaks at a time ii. Remind participants respectfully of ground rules iii. Ask if participants have something they would like to share with the group iv. Take a short break f. Participants Skip Ahead i. As long as participants are discussing the topics, allow them to move ahead 38 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia ii. Probe and clarify in order to obtain adequate response to question iii. Return to previous topics to ensure all FGD questions are answered g. Participants Begin Leaving i. Provide a time check ii. Consider focusing on the most important issues before finishing E. Note Taker: the Note take will be carefully selected to have the following skills. a) Have good listening skills b) Have good observation skills c) Have good writing skills d) Are able to take notes that are comprehensive but not word-for-word e) Use the note taking form provided f) Act as an observer, not as a participant g) Can remain impartial (i.e., do not give her/his opinions about topics, because this can influence what people say) F. Important guides to for Note Taking: a) Record major themes, ideas, comments and observations regarding group dynamics b) Use Note Taking Form c) Document verbal and non-verbal communication d) Document level of consensus among participants e) When in doubt, don’t leave it out! f) Distinguish clearly between participant comments and your own observations g) Do not throw away any papers with notes of the focus group discussion. h) In evening, facilitator/interviewers and note takers should review and consolidate notes to ensure complete documentation i) Capture any new insights that emerged as a result of this discussion with the facilitator/interviewer. j) Save all notes from FGDs G. A Quick Guide To Focus Group Analysis: a) Read through all the answers to a question (from all the focus group transcripts/notes), looking for patterns and similarities. b) Use the note Taking Form to keep key points together and organized. If a key point is repeated, place a tally mark next to that point. For example, if in answer to the question “What did you like about the savings group?” one participant said “I made new friends,” and another said “It gave me a chance to socialize” then the key point would be “socializing,” followed by 2 tally marks. Continue listing key points until every answer has been accounted for. c) When summarizing the overall response to that question, consider: d) Frequency - how many times the key point was made by different people e) Specificity - how detailed particular responses were f) Emotions - how much emotion, enthusiasm, or intensity was expressed in a particular answer? g) Select a few quotes from the transcript to illustrate and provide insights for your summary. 39 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia A1.4 STEP FGD Questionnaire FGD Questionnaires for ETU Staff 1. How would you justify the service provided by the ETU were high standard and as per the MoH/WHO protocol for EVD care? 2. How would you justify if Ganta ETU have been consistently meeting Liberia Minimum Standards for Safe Care Provision by Healthcare Facilities in the Context of Ebola? 3. What was your direct contribution to maintain the quality of services to be high standard and quality services and as per the MoH protocol for EVD care? 4. What were the supports Ganta ETU providing to Ebola affected families and orphans at the ETU and community level? 5. How had the ETU supported Ebola affected families and orphans to settle and integrate into their community? 6. As a staff of the ETU, what had been the low point of your involvement in the project – things you were not happy with/ disappointed or regretted of happening? Why? 7. If this were the time when the Ebola outbreak being, what would you differently that you have not done in the past? 8. Over all, what do think is the key achievements of PCI/STEP during the course of the project implementation that you believe could make the most difference to strengthening the IPC implementation in Nimba County? Thank you for your time and contributions 40 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Annex 2: List of Indicators and Results Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes Goal: Manage the MOHSW-staffed Ebola Treatment Unit (ETU) in Ganta in order to slow the spread of Ebola in Nimba County through the isolation of cases, the provision of a high standard of medical care, and the protection of individuals at the ETU affected by the Ebola outbreak. Sector: Health / Sub-Sector 1: Health Systems and Clinical Support 1.1.1 Ganta ETU consistently meets Liberia Minimum Standards for Safe Care Provision by Healthcare Facilities in the Context of Ebola NA NA 100% 100% Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. 1.1.2 Ganta ETU WASH facilities consistently meets the Minimum WASH Requirement – Ebola Treatment Unit NA NA 100% 100% Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. 1.1.3 Number of healthcare facilities supported and/or rehabilitated to treat cases of Ebola by type (e.g. Primary, Secondary, Tertiary 0 Primary 69 1 ETU Reported monthly per PMP; required indicator per USAID/OFDA guidelines Secondary 5 Tertiary 4 1.1.4 Number of healthcare providers trained by 0 Doctors Males 15 1270 Target revised in project modification Females approved Nov 2015. Reported monthly per 6 41 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes type (e.g. doctor, nurse, hygienists, physician assistants, midwives, etc.), by sex Sub-Total 21 PMP; required indicator per USAID/OFDA guidelines; should include by type "doctor, nurse, community health worker, midwife, and traditional birth attendant." Nurse Males 252 Females 368 Sub-Total 620 Hygienists Males 217 Females 170 Sub-Total 387 Physician assistants Males 35 Females 8 Sub-Total 43 Midwives Males 4 Females 53 Sub-Total 57 Others Males 1073 Females 1247 Sub-Total 2320 Total 3448 1.1.5 Number and percentage of health facilities submitting weekly surveillance reports 0 NA 1 1 Required indicator per USAID/OFDA guidelines 0% 100% 100% 42 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes 1.1.6 Number of consultations, by sex and age, per quarter 0 0 - 11 mo Males 656 4,400 By quarter; required USAID/OFDA indicator Females 608 Sub-Total 1264 1 - 4 yrs Males 1924 Females 1956 Sub-Total 3880 5 - 14 yrs Males 527 Females 593 Subtotal 1120 15 - 49 yrs Males 652 Females 1219 Sub-Total 1871 50 - 60 yrs Males 152 Females 243 Sub-Total 395 60+ yrs Males 119 Females 216 Sub-Total 335 All Ages Combined Males 4030 Females 4835 Total 8865 43 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes 1.1.7 Number of community events to strengthen community resilience and /or preparedness NA Total 42 24 1.1.8 Number of Healthcare Facilities at which staff are mentored by ETU staff on minimum standards for IPC, triage and use of PPE NA Total 46 24 Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. 1.1.9 Number of healthcare providers mentored by ETU staff on minimum standards for IPC, triage and use of PPE NA All Districts Male 428 324 Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. Female 439 Total 867 1.1.10 Percent of days that contaminated objects/surfaces are disinfected with chlorine solution NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 1.1.11 Percent of days that all contaminated liquid wasted are disinfected and disposed of in designated, secured site NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 44 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes 1.1.12 Percent of observations of Handwashing Stations where water and soap were both present NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 1.1.13 Percent of days in which 70 liters of water per staff per day were available at the ETU NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 1.1.14 Percent of days in which 2 days of buffer water storage were maintained at the ETU NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 1.1.15 Percent of drinking water samples from the ETU which had a minimum of 0.5 mg/L (ppm) free residual chlorine (FRC) NA NA 100% 100% Indicator removed in the project modification approved in Nov 2015 Sector: Health / Subsector 2: Medical Commodities Including Pharmaceuticals 1.2.1 Number and percentage of health facilities, supported by USAID/OFDA, out of # NA NA 0 0 Essential medicines include those for managing symptoms (fever, pain discomfort, confusion/aggression, hiccups, vomiting, seizures, ulcers, rash), 45 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes stock of selected essential medicines and tracer products for more than 1 week % NA 0% 0% rehydration, testing and treating common conditions with symptoms similar to EVD; required indicator per USAID/OFDA guidelines 1.2.2 Number of people trained, by sex, in the use and proper disposal of medical equipment and consumables 0 Males 1597 1,970 Target revised in the modification in Nov 2015. Required indicator per USAID/OFDA guidelines Females 1851 Total 3448 1.2.3 Number of supplies distributed by type 0 County and Local Medical Kits 0 285,795 For consistency across the various supplies, each item is reported based on the smallest unit possible. Supplies for the effective control of Ebola virus, including sanitation materials and PPE; reported monthly; required indicator per USAID/OFDA guidelines Equipment 5295 Consumables/supplies 585815 Sub-Total 591110 International Procurement Medical Kits 0 Equipment 7,664 Consumables/supplies 989,188 Sub-Total 996,852 Combined (County, Medical Kits - 46 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes Local, International) Equipment 13,799 Consumables/supplies 1,575,003 Total 1,588,802 Sector: Protection / Sub-Sector 1: Child Protection 2.1.1 Average # of weeks required for resettlement of Ebola orphans back into a family or community setting NA NA 1 4 Reported as an average number of weeks. This indicator is included to fulfill USAID/OFDA requirement for second indicator that measures protection outcomes of the proposed activities 2.1.2 Number of people trained in child protection 0 Males 56 30 Target revised in the modification Nov 2015. Required indicator per USAID/OFDA guidelines, including disaggregation by sex Females 16 Total 72 2.1.3 Number of Ebola orphans resettled into a family or community setting. NA NA 11 TBD Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. 47 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Ind # Indicator Base-line Disaggregation LOP Total (to date) LOP Target Notes 2.1.4 Number of Ebola affected individuals resettled into their community. NA NA 0 TBD Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. 2.1.5 Ganta ETU has a Child Protection Policy in place NA The ETU is using the MoHSW protocol 1 1 Note that even though this is a new indicator added in the project modification approved in Nov 2015, we were collecting this data before and have, therefore, reported the information here. * Age ranges are as follows: 0-11 months, 1-4 years, 5-14 years, 15-49 years, 50-60 years, and 60+ years, per USAID/OFDA guidelines (Source: STEP Quarterly Indicator Performance Tracking Table for the period of Jan 1 – March 31, 2016. PCI, April 21, 2016) 48 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Annex 3: Medical Commodities and supplies used/distributed by STEP S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total Medicines 1 Alcohol Hand Gel Btts 0 649 649 0 649 649 2 Alumimium hydroxide 500mg Tablets 0 500 500 0 500 500 3 Amoxicillin (250mg) Tabs 0 0 7200 0 7200 4 Amoxicillin 125mg oral susp Bottles 0 9 9 0 9 9 5 Amoxicillin 250mg capsules BP STRIPS 0 13 13 0 13 13 6 Amoxicillin 500mg cap 0 0 5370 0 5370 7 Amoxicillin 500mg capsules BP STRIPS 0 12 12 0 12 12 8 Antibactrium dressing jell Bottles 0 9 9 0 9 9 9 Antibiotic Ointment Tubes 0 0 0 3 0 3 10 Antibiotic Pain Relief Cream Tubes 0 0 0 15 0 15 11 Anticide 500mg Tabs 0 0 0 1000 0 1000 12 Artemether (15kg less than 20kg) ( Coartem) Strips 0 227 227 0 227 227 13 Artemether 20mg+Lumefantrine 120mg 5kg<15kg STRIPS 0 30 30 0 30 30 14 Artemether 20mg+Lumefantrine 120mg 35kg above STRIPS 0 110 110 0 110 110 15 Artesunate 60mg IV vial 211 211 156 211 367 16 Ascorbic Acid 250mg Tabs 900 900 2000 900 2900 17 Atropin salphate AMPS 0 100 100 0 100 100 18 Avelox 400mg Tablets 0 420 420 0 420 420 19 Azithromycin 250mg Tablets 0 6 6 0 6 6 20 Bactigel pcs. 1 6 7 1 6 7 21 Calcium Gluonat AMPS 2 300 302 2 300 302 22 Cefixicime (400mg) Tabs 0 0 120 0 120 23 Cefixime 200mg Tablets 0 3,948 3948 0 3948 3948 24 Cefixime 200mg/tablet Tablets 0 16,504 16504 0 16504 16504 25 Ceftriaxone Vials 0 0 50 100 150 26 Ceftriaxone 1000mg vial 0 0 94 0 94 27 Ceftriaxones sodium Eq 1 g base power vial Vials 0 2,885 2885 0 2885 2885 28 Ceftriaxones sodium Eq 250mg base power vial Vials 0 15,950 15950 0 15950 15950 29 Chloramphenicol 1g vial 0 10 0 10 30 Cimetidine 200mg amp 0 10 0 10 31 Cimetidine 400mg Tabs 0 50 0 50 32 Ciprofloxacin (250mg) Tabs 0 1600 0 1600 33 Ciprofloxacin (500mg) Tabs 630 630 4000 630 4630 34 Ciprofloxacin 500mg tabs pacs 10 PKS 0 3800 3800 0 3800 3800 35 Coartem 15-25kg Strip 30 30 443 30 473 49 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 36 Coartem 25-35kg Strip 59 59 340 59 399 37 Coartem 35 above Strip 175 175 349 175 524 38 Coartem 5-15kg Strip 30 30 480 30 510 39 Co-trimaxazole syrup btts 40 40 160 40 200 40 Co-trinoxazole 120mg Tablets 0 3960 3960 0 3960 3960 41 Dexamethasone(4mg/ml) Amp 2350 2350 190 2350 2540 42 Dextouse-5% Btts 12 12 24 72 96 43 Dextros-50% (D-50%) Btts 0 42 60 102 44 Dextroxe 5% ( 1000ml ) CRT 0 120 120 0 120 120 45 Diazapan 10mg amp 0 23 0 23 46 Diazepam 5mg Tablets 0 1830 1830 0 1830 1830 47 Dispensing bag pcs 1800 1800 3200 1800 5000 48 DNS 1000ml Btts 258 258 80 288 368 49 Doxycline 100mg Tabs 0 1060 0 1060 50 Epinephrine 1mg/ml amp box 10 BOXES 0 3,500 3500 0 3500 3500 51 Epinephrine Galenica Senese pks. 0 1,200 1200 0 1200 1200 52 Epinphrine Galenica IV AMPS 0 500 500 0 500 500 53 Erythromycin (333mg Tabs 0 459 0 459 54 Ferrous Tabs 3000 3000 4000 3000 7000 55 Furesemide pcs. 0 100 100 0 100 100 56 G-50% Btts 0 1 0 1 57 Galenica H2O vial pcs. 0 400 400 0 400 400 58 Gentamicin(40mg/ml) Amp 0 400 0 400 59 Gentamycin 80mg amp 0 30 0 30 60 Gestifloxacin (Eye Drop) Btts 0 4 0 4 61 Girl Friend Hand & Body Lotion bts. 0 9 9 0 9 9 62 Glenica senese water for injection AMPS 0 400 400 0 400 400 63 Glucose 5% 500ml/box 20 bts. 0 1,708 1708 0 1708 1708 64 Glucose 50% IV GV Vials 0 927 927 0 927 927 65 Glucose Inj. 50% W/v bts. 0 854 854 0 854 854 66 Glucose Injection pks. 0 5 5 0 5 5 67 Haloperidol 5mg for Injection 5mg in 1ml AMPS 0 11,000 11000 0 11000 11000 68 Hydrocorlisone sodium succinate IV 100mg Vials 0 2,900 2900 0 2900 2900 69 Hydrocortisone 100mg Vials 0 43 0 43 70 Hyoscine 20mg amp 300 300 20 300 320 71 Infusion set kit pcs. 0 2280 2280 0 2280 2280 72 Lansoprazole (30mg) Tabs 0 630 0 630 73 Levofloxacin (500mg) Tabs 0 1000 0 1000 74 Levofloxacin (750mg) Tabs 0 1900 0 1900 75 Magellan (1ml Insulin Safety Syringe) pcs. 0 0 0 50 0 50 50 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 76 Mebendazole 500mg Tabs 0 0 500 0 500 77 Metoclopramide amp 0 4000 4000 100 4000 4100 78 Metro infusion 500mg btts 0 0 4 0 4 79 Metroclopramide 10mg Tabs 0 101,750 101750 1000 101750 102750 80 Metroclopromide 500mg amp 0 0 2450 150 2600 81 Metronidazole 250mg Tabs 0 0 73 0 73 82 Metronidazole 500mg Tabs 0 200 200 8051 200 8251 83 Metronidazole 5mg AMPS 0 100 100 0 100 100 84 Metronidazole IV Bottles 0 416 416 0 416 416 85 Morphine sulfate 10mg Tablets 0 12,000 12000 0 12000 12000 86 Morphine sulfate IV AMPS 0 3,950 3950 0 3950 3950 87 Multi-Symptom cold btts 0 0 3 0 3 88 Multi-vitamin 200mg Tabs 0 0 5101 1000 6101 89 Neosporin+ pain relief tubes 0 3 3 0 3 3 90 Normal Saline 1000ml btts 0 0 66 30 96 91 Nystatin USP 100,000IU Tablets 0 200 200 0 200 200 92 Omeprazole 20mg PK 0 8 8 0 8 8 93 Omeprazole(40mg) Amp 0 0 88 0 88 94 ORS Sachet 0 20000 20000 4000 20000 24000 95 ORS Low osm 20.5g/L CAR/100 Sachet 0 55,500 55500 0 55500 55500 96 Oxytocin 10IU AMPS 0 10 10 0 10 10 97 Paracetamol 100mg Tabs 0 30200 30200 5200 30200 35400 98 Paracetamol 125mg oral solution Bottles 0 475 475 0 475 475 99 Paracetamol 125mg/5ml, 60ml solution Bottles 0 580 580 0 580 580 100 Paracetamol 325 mg Tabs 0 980 980 58 980 1038 101 Paracetamol 500mg Tabs 0 0 9450 0 9450 102 Paracetamol 500mg tabs pacs 100 PACK 0 12,163 12163 0 12163 12163 103 Paracetamol syrup btts 0 0 70 0 70 104 Paracetamol syrup 100mg btts 0 0 3 0 3 105 Povidone Iodine solution 10% bottle 200ml PCS 0 400 400 0 400 400 106 Promethazine 25mg Tabs 0 42000 42000 2100 42000 44100 107 Ringer Lactate 1000ml btts 0 108 108 86 132 218 108 Robitussin 20mg Tablets 0 800 800 0 800 800 109 Salbutamol 4mg Tabs 0 90 90 100 90 190 110 Salbutmol sulfate 0.1mg/puff 200 puff, aerosal pcs 0 200 200 0 200 200 111 Septrim 480 mg Tabs 0 0 2000 0 2000 112 Silvrstat (Antibacterial wound dressing gel) 0 94 94 0 94 94 113 Sodium chloride 0.9% Bottles 0 747 747 0 747 747 51 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 114 SODIUM LACTATE Comp inj 1000ml w/g. set box 10 PCS 0 2,068 2068 0 2068 2068 115 SODIUM LACTATE Comp inj 500ml w/g. set box 50 PCS 0 4,160 4160 0 4160 4160 116 Sterile water 1000ml Btts 0 60 60 0 60 60 117 Tetracycline 1% tubes 0 500 500 0 500 500 118 Vitamin A oral cap 0 2,500 2500 0 2500 2500 119 Water for injection 10ml plastic ampule PCS 0 24,000 24000 0 24000 24000 120 Zinc 20mg tablets, pac 100 PKS 0 3,400 3400 0 3400 3400 121 Zinc sulfate 20mg Tablets 0 5,300 5300 0 5300 5300 Medical Supplies and consumables 122 3M particulate Respiratory mask Pcs 0 7,680 7680 0 7680 7680 123 Absorbent Cotton Guaze Swab ( 10 x 10cm ) ROLL 0 1,035 1035 0 1035 1035 124 ABSORBENT COTTON GUAZE SWAB ROLL 0 4,800 4800 0 4800 4800 125 ABSORBENT COTTON GUAZE SWAB (7.5X7.5 CM) ROLL 0 214 214 0 214 214 126 ABSORBENT COTTON WOOL (500G) ROLL 0 183 183 0 183 183 127 ABSORBENT GAUZE PAD Pcs 0 504 504 0 504 504 128 ABSORBENT PAD PCS 0 1,500 1500 0 1500 1500 129 Adhesive tape roll 0 114 114 11 114 125 130 Adult Diapers Large Size Case 0 717 717 0 717 717 131 Adult Diapers Madium/regular size CASE 0 144 144 0 144 144 132 Adult Diapers small size CASE 0 144 144 0 144 144 133 AERO CHAMBER PCS. 0 18 18 0 18 18 134 Alcohol and Betadine Pads & Swabs PCS 0 4,950 4950 0 4950 4950 135 ALCOHOL PAD PCS 0 500 500 0 500 500 136 Applicator Swabs (Q-Tips), Tongue Depressors, Cotton Balls PCS 0 16,000 16000 0 16000 16000 137 Applicator Swabs (Q-Tips), Tongue Depressors, Cotton Balls PCS 0 5,600 5600 0 5600 5600 138 Assorted Anesthetic materials pcs 0 0 0 1500 1500 139 Assorted Foley catheter pcs 0 0 0 503 503 140 Assorted Guazes and Bardanges ROLL 0 244 244 0 244 244 141 Assorted IV cannulas pcs 0 0 0 0 2013 2013 142 Assorted lubricating gel pcs 0 0 0 0 5107 5107 143 Assorted medical gel pcs 0 0 0 0 503 503 144 Assorted skin lotion Btts 0 0 0 0 76 76 145 Assorted wound dressing materials pcs 0 0 0 0 210 210 52 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 146 BABY JOHNSON POWDER PCS 0 99 99 0 99 99 147 Bandage roll 0 0 15 0 15 148 Bandages elastic ROLL 0 91 91 0 91 91 149 Bandages gauzes ROLL 0 282 282 0 282 282 150 Bandaids, Steristrips, Tape, Transparent Dressings ROLL 0 8,500 8500 0 8500 8500 151 Bandaids, Steristrips, Tape, Transparent Dressings (tegaderm) PCS 0 21,909 21909 0 21909 21909 152 BD SYRINGE (10ML) PCS 0 600 600 0 600 600 153 BD VACUTAINER PKS 0 3,000 3000 0 3000 3000 154 BD VACUTAINER REF: 364815 PCS 0 200 200 0 200 200 155 Blood Access tray Set 0 0 6 6 156 Blood collection tubes pcs 0 0 36 36 157 Blood Drawing Supplies (Vacutainer Holders & Needles, Butterflies, Lancets, Tourniquets) pcs 0 9,464 9464 0 9464 9464 158 BLOOD LANCET PCS 0 10 10 0 10 10 159 Blood transfusion tubing pcs 0 0 0 0 73 73 160 Bottle plastic 250ml, wash bottle PCS. 0 21 21 0 21 21 161 BREATHING CIRCUIT PCS. 0 58 58 0 58 58 162 Broom and stick PCS. 0 4 4 0 4 4 163 Buffalo Caps, Prn Adaptors And Other IV Infusion Supplies, Vial Spikes And Adaptors PCS 0 6 6 0 6 6 164 Bulb Syringe ( 60ml ) PCS 0 74 74 0 74 74 165 Cannula 16g pcs 0 781 781 0 781 781 166 Cannula 18g pcs 2008 2008 15 2008 2023 167 Cannula 20g Pcs 2126 2126 54 2126 2180 168 Cannula 22g pcs 3459 3459 37 3459 3496 169 Cannula 24g Pcs 530 530 35 530 565 170 Cannulas (23g) Pcs 0 97 97 0 97 97 171 Canulas ( 14g ) Pcs 0 303 303 0 303 303 172 CHEMSPLASH (ENVRO GUARD) PCS 0 780 780 0 780 780 173 Children's Diapers Cases 0 210 210 0 210 210 174 Cidex Solution test strip pcs 0 0 311 311 175 COMMODE TOILET TAP PCS 0 2 2 0 2 2 176 Cotton Roll 0 6 1 7 177 COTTON BALLS PKS 0 95900 95900 0 95900 95900 178 Cotton roll pcs 0 1 1 0 1 1 179 COTTON WOOL (500G) ROLL 0 45 45 0 45 45 180 CREPE BANDAGE (10CM X 45M) PKS 0 135 135 0 135 135 181 Disposable Bedding Kits PCS 0 164 164 0 164 164 53 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 182 Disposable Syringes 2/3ml pcs 0 300 300 0 300 300 183 Disposable syrings 5ml pcs 0 1,183 1183 0 1183 1183 184 DRAINABLE POUCH PCS. 0 2 2 0 2 2 185 Drapes Non-Sterile PCS 0 760 760 0 760 760 186 ELASTIC BANDAGE (8CM X 5CM) ROLL 0 1,120 1120 0 1120 1120 187 ELASTIC EARLOOP FACE MASK PCS 0 65,400 65400 0 65400 65400 188 ELASTIC GUAZE BANDAGE (10CM X 4M) ROLL 0 5,000 5000 0 5000 5000 189 ELASTIC GUAZE BANDAGE (6CM X 10CMX 4M) ROLL 0 8,000 8000 0 8000 8000 190 ELASTIC GUAZE BANDAGE (6CM X 4M) ROLL 0 20 20 0 20 20 191 EMPTY BOTTLES FOR DRUG (MEDICINE) PCS 0 45 45 0 45 45 192 EPIDURAL LINES PCS. 0 50 50 0 50 50 193 FEEDING TUBE (100CM) PCS 0 95 95 0 95 95 194 FEEDING TUBE (40CM) PCS 0 200 200 0 200 200 195 FEEDING TUBE ADJUSTABLE (ADULT 120CM) (PEDIATRIC 40CM) PCS 0 200 200 0 200 200 196 First infant milk btts 0 18 0 18 197 FOG FREE PROCEDURE MASK SO SOFT LINNING PCS 0 400 400 0 400 400 198 Foley bags Pcs 0 6 0 6 199 Foley Balloon catherter 18fr pcs 0 219 219 0 219 219 200 Foley catheter Set 0 17 61 78 201 FOLEY TRAY WITH BARD pks. 0 35 35 0 35 35 202 Gauze And All Other Non-Sterile Dressings PCS 0 875 875 0 875 875 203 GAUZE PAD (10 X 10) CM PCS 0 250 250 0 250 250 204 GAUZE PAD (10 X 10) CM PCS 0 200 200 0 200 200 205 Gauze pad 2x2, 4x4 box 0 0 1 1 206 GAUZE SWABS (10 X 10) CM. 8 FACH/PLY PCS 0 1,000 1000 0 1000 1000 207 GAUZE SWABS (7.5 X 7.5) CM. 8 FACH/PLY PCS 0 2,000 2000 0 2000 2000 208 Gloves PCS 0 60 60 0 60 60 209 Gloves Exam, latex, power free, medium box 100 PCS 0 21 21 0 21 21 210 Gloves, Sterile Pair 0 500 500 0 500 500 211 Glucose Meters Pks 0 4 0 4 212 GRAVITY FEEDING BAG PCS. 0 30 30 0 30 30 213 GURNEY first KITS PCS 0 500 500 0 500 500 214 High Quality Bopp Tape PCS 0 50 50 0 50 50 54 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 215 HOSPITAL BED (Gurney) PCS 0 2 2 0 2 2 216 HOSPITAL MATRESS PCS 0 12 12 0 12 12 217 I.V. CATHETER WITH WINGS AND INJECTION PORT (18G/45MM. (1 3/4")MM PCS 0 700 700 0 700 700 218 INFUSION GIVING SET PCS 0 3,628 3628 0 3628 3628 219 Infusion set tubes 0 0 0 0 0 220 INLINE BURETTE SET 150ml PCS. 0 18 18 0 18 18 221 INNER CANNULAS PCS. 0 60 60 0 60 60 222 IRRIGATION SYRINGES TUBES AND TRAYS PCS. 0 21 21 0 21 21 223 IV / NG tubing Pcs 0 447 0 447 224 Iv Cannulas 20g Pcs 0 0 50 50 225 Iv Cannulas 22g Pcs 0 0 50 50 226 IV Cannulas 24g Pcs 0 0 50 50 227 IV CATHETER 14g PCS. 0 303 303 0 303 303 228 IV CATHETER 16g PCS. 0 407 407 0 407 407 229 IV CATHETER 18g PCS. 0 1,824 1824 0 1824 1824 230 IV CATHETER 20g PCS. 0 2,070 2070 0 2070 2070 231 IV CATHETER 22g Pcs. 0 3,309 3309 0 3309 3309 232 IV CATHETER 24g PCS. 0 480 480 0 480 480 233 IV CATHETER/HUBER, BUTTERFLY FISTULA PCS. 0 400 400 0 400 400 234 IV Primary Tubing PCS 0 1,617 1617 0 1617 1617 235 IV START KIT PCS. 0 100 100 0 100 100 236 IV SYSTEM DIMISION pks. 0 600 600 0 600 600 237 IV tubing Pcs 0 100 200 300 238 IV TUBING/NG TUBING PKS 0 1725 1725 0 1725 1725 239 Lancet Pcs 0 0 100 100 240 LATEX SURGICAL GLOVES PCS 0 5,000 5000 0 5000 5000 241 LIMB HOLDER+ PCS. 0 6 6 0 6 6 242 LINERS, TRASH, CAN LAUNDRY PCS 0 24 24 0 24 24 243 Lubricating Gel PCS 0 60 60 0 60 60 244 Magellan 1m Syringes pcs 0 50 50 0 50 50 245 Malaria Test pcs 0 170 0 170 246 Medication Cup Pcs 0 0 50 50 247 NASAL CANNULAS ( Oxygen Mask) PCS. 0 197 197 0 197 197 248 NASAL OXYGEN CANNULA PCS. 0 238 238 0 238 238 249 Needles (21G) Pcs 0 2024 2000 4024 250 NEEDLES 19g PCS. 0 12,200 12200 0 12200 12200 251 NEEDLES 21g PCS. 0 11,600 11600 0 11600 11600 55 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 252 NEEDLES 22g PCS. 0 100 100 0 100 100 253 NEEDLES 23g PCS. 0 400 400 0 400 400 254 NG Tube 6fr pcs 0 39 39 0 39 39 255 NG Tube 8fr pcs 0 51 51 0 51 51 256 Nitrile Powder Free Midical Examination gloves ( Medium ) PCS 0 7,200 7200 0 7200 7200 257 Nitrile Powder Free Midical Examination gloves ( Small) PCS 0 2,000 2000 0 2000 2000 258 Nulife B alloon catherter 14fr pcs 0 84 84 0 84 84 259 ORAL NASAL TRACHEAL TUBES PCS. 0 48 48 0 48 48 260 Oxygen face mask Pcs 0 5 0 5 261 Oxygen nasal prong Pcs 0 9 0 9 262 PATIENT BED SHEETS (60 X 90) CM PCS 0 188 188 0 188 188 263 PATIENTS BED SHEETS (40 X 60) CM PCS 0 1,500 1500 0 1500 1500 264 Pediatric IV tubing pcs 0 0 103 103 265 PILLOWS PCS 0 67 67 0 67 67 266 Plastic disposable ampule opener BOX 0 100 100 0 100 100 267 PLASTIC MEDICINE BAG ( Dispensing Bag ) PCS 0 2,800 2800 0 2800 2800 268 Plston Syringes 60ml pcs 0 50 50 0 50 50 269 Plumpy Nuts Pcs 0 13 0 13 270 Power Milk (F-75) Pcs 0 10 0 10 271 PRESSURE INFUSER PCS. 0 64 64 0 64 64 272 Radial artery catheter tray Pks 0 0 23 23 273 SILICONE COATED LATEX FOLEY CATHETER pks. 0 96 96 0 96 96 274 Specimen Bag pcs 0 74 74 0 74 74 275 specimen CUPS PCS 0 700 700 0 700 700 276 SPECIMEN CUPS PCS. 0 100 100 0 100 100 277 SPONGE FOAM MATTRESS PCS 0 22 22 0 22 22 278 Sterile needles pcs 0 8,300 8300 0 8300 8300 279 STOMACH TUBE (125CM) PCS 0 75 75 0 75 75 280 STOMACH TUBE/ Dual Limen PCS. 0 54 54 0 54 54 281 Straight catheter pcs 0 0 125 125 282 STRETCHER SHEET (WHITE & BLUE) PCS 0 1,600 1600 0 1600 1600 283 Surgical gloves Pairs 0 3720 3720 2210 5070 7280 284 surgical mask pcs 0 0 0 320 0 320 285 surgical mask 3-M pcs 0 0 0 1080 0 1080 286 Surgical Skin Marker PCS 0 32 32 0 32 32 56 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 287 SUTURE POLYPROPYLENE PKS. 0 396 396 0 396 396 288 SWABSTICK PCS. 0 71 71 0 71 71 289 SYRING PCS. 0 31 31 0 31 31 290 SYRINGE (2ML) PCS 0 3,600 3600 0 3600 3600 291 Syringe (5ml) Pcs 1606 1606 300 1706 2006 292 SYRINGE [50ML) PCS 0 0 0 0 0 293 Syringe 10ml pcs 0 342 25 367 294 Syringe 12ml pcs 12,849 12849 30 12849 12879 295 Syringe 6ml Pcs 2,100 2100 16 2100 2116 296 Syringe(2/3ml) Pcs 0 100 100 200 297 Syringe(20ml) Pcs 216 216 144 256 400 298 Syringe 3ml pcs 0 1,500 1500 0 1500 1500 299 Syringes 30ml-BD PCS 0 31 31 0 31 31 300 Syringes 3cc ( With needles-20g) PCS 0 47 47 0 47 47 301 Syringes 3cc ( With needles-21g) PCS 0 239 239 0 239 239 302 Syringes Hypodermic safety needls pcs 0 150 150 0 150 150 303 Syringes, 1 cc/tb PCS 0 6,923 6923 0 6923 6923 304 Syringes, 10cc & 12cc PCS 0 7,563 7563 0 7563 7563 305 Syringes, 3cc ( With needles- 23g ) PCS 0 11,281 11281 0 11281 11281 306 TRANS-PAC BIFUCATED MMONITORING PCS. 0 5 5 0 5 5 307 Underpads, (Chux and Blue Pads) PCS 0 4 4 0 4 4 308 Urinary Catheters ( Straight) PCS 0 563 563 0 563 563 309 Urinary Drainage Bags PCS 0 14 14 0 14 14 310 URINARY/Uro-Trapper Drain Bag PCS. 0 10 10 0 10 10 311 Vaseline PCS 0 72 72 0 72 72 312 Veno Catheter (18g) Pcs 0 0 0 30 0 30 313 Veno Catheter (20g) Pcs 0 0 0 30 0 30 314 Veno Catheter (22g) Pcs 0 0 0 30 0 30 315 Vinyl Pillow Case PCS 0 18 18 0 18 18 316 VOLUMETRIC INCENTIVE SPIROMETER PCS. 0 15 15 0 15 15 317 WHITE BED SHEET PCS 0 35 35 0 35 35 318 WOODEN TONGUE DEPRESSOR PCS 0 900 900 0 900 900 IPC Supplies and Commodities 319 Abd Sterile Dressings 2x2, 4x4, Pcs 0 5 5 0 5 5 320 Accent cleansing wash btts 0 116 0 116 321 Alcohol Btts 113 113 0 137 137 322 ANTIBACTERIAL LOTION SOAP WITH MOISTERIZERS LITER 0 6 6 0 6 6 323 Applicator swab pcs 0 0 800 800 324 Apron protection PCS. 0 850 850 0 850 850 57 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 325 Aprons (Green Aprons) PCS. 0 90 90 0 90 90 326 Aprons (Surgical Aprons) PCS 0 300 300 0 300 300 327 Bactigel Hand sanitizer Bottles 0 3 3 0 3 3 328 BATH SOAP (BROWN) WARREN TRICOMI CAKES 0 3,687 3687 0 3687 3687 329 Bathing soap Cakes 0 999 0 999 330 Bathing towel Pcs 0 5 0 5 331 Bed sheet Pcs 0 15 56 71 332 Bio hazard bags (Plastic Roll Black) Roll 0 99 99 0 99 99 333 BLACK BUCKET PLASTIC PCS 0 143 143 0 143 143 334 blanket Pcs 0 8 0 8 335 Blanket/Bed sheet Pcs 0 19 50 69 336 Bleach Gal 0 390 198 588 337 Bleach Classic gal 0 467 0 467 338 Bleach Classic btts 0 587 0 587 339 Bleach Classic (128 oz. Gallons) Gasl 0 2914 2914 0 2914 2914 340 Body bag pcs 0 0 90 90 341 Bopp Tape roll 0 6 0 6 342 BOUFFANT CAP( Blue ) PCS 0 3500 3500 0 3500 3500 343 Broom with stick Pcs 0 9 0 9 344 Brushes ( Black) PCS 0 48 48 0 48 48 345 BUCKET Without hole)-Small PCS 0 69 69 0 69 69 346 Bucket + Lid, White plastic PCS. 0 22 22 0 22 22 347 Bucket 20L with hole PCS. 0 11 11 0 11 11 348 Bucket with top PCS. 0 100 100 0 100 100 349 Buto-Asma pks 0 4 0 4 350 Buto-asna pks 0 45 45 0 45 45 351 Children clothes Pcs 0 21 0 21 352 Children Diaper size 3 PCS 0 186 186 0 186 186 353 Children Diaper size 4 PCS 0 160 160 0 160 160 354 Chlorine Btts 0 4 5 9 355 Chlorine (25kg) Bucket 202 202 7 202 209 356 Chlorine (45kg) Bucket 0 8 0 8 357 Clean & Fresh Liquid soap btts 0 27 0 27 358 Clean and Fresh Btle 0 35 35 0 35 35 359 Cleansing Wash Btts 0 142 0 142 360 Clorox (Bleach) Gals 0 63 63 0 63 63 361 Clothing Detergent (40lb pail) GAL 0 3 3 0 3 3 362 Condom Box 0 0 0 1544 0 1544 363 Containers, Basins, Emesis, Water Mugs, Pitchers, Glassware pcs 0 1,601 1601 0 1601 1601 58 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 364 Cup 250ML, green PCS 0 89 89 0 89 89 365 DANLINE / TWINE ROPE BOXES 0 6 6 0 6 6 366 DETERGENT POWDER SOAP( KLIM SOAP) Sachet 0 378 378 0 378 378 367 DETOL (ANTISEPTIC DISINFECTANT) Bottle 0 18 18 0 18 18 368 Dettol btts 0 77 0 77 369 Diamond- PLASTIC WRAP PCS 0 15 15 0 15 15 370 Disinfectant and Skin Cleansing Products pcs 0 1,476 1476 0 1476 1476 371 Disposable Aprone Pcs 0 100 0 100 372 Disposable cups Pcs 0 926 100 1026 373 Disposable Examination gloves pcs 0 15900 176000 191900 374 Disposable Face mask with anti-fog shield (2 boxes, 200 per box) CRT 0 800 800 0 800 800 375 Disposable fork Pcs 0 500 0 500 376 DISPOSABLE HOOD ( E- HOOD ) PCS 0 4500 4500 0 4500 4500 377 Disposable plate Pcs 0 1288 0 1288 378 Disposable Plates Pcs 0 202 100 302 379 Disposable spoon pcs 0 914 0 914 380 Disposable Spoons Pcs 0 106 100 206 381 Drape Sterile pcs 0 0 28 28 382 Drapes, Non-sterile PCS 0 336 336 0 336 336 383 Drapes, sterile PCS 0 712 712 0 712 712 384 Dressing Change Kits, Laceration Trays, wound Care PCS 0 52 52 0 52 52 385 Duct Tape roll 0 11 0 11 386 Emergency Cadaver Bag PCS 0 15 15 0 15 15 387 Examination Gloves ( XL ) Pair 0 1,700 1700 0 1700 1700 388 EXAMINATION GLOVES POWDER FREE LATEX ( XL) BOXES 0 150 150 0 150 150 389 Examination gloves Pcs 560 560 5720 1560 7280 390 Examination Gloves (L) PCS 0 5,750 5750 0 5750 5750 391 Examination Gloves (M) PKS 0 5,500 5500 0 5500 5500 392 Examination Gloves (S) PKS 0 5,100 5100 0 5100 5100 393 EXAMINATION GLOVES POWDER FREE, LATEX (L) PCS 0 2,000 2000 0 2000 2000 394 EXAMINATION GLOVES POWDER FREE, LATEX (M) PCS 0 25,000 25000 0 25000 25000 395 EXAMINATION GLOVES POWDER FREE, LATEX (S) PCS 0 4,000 4000 0 4000 4000 396 Exergen pcs 0 12 12 0 12 12 397 Eye wash refill bottles BTS. 0 6 6 0 6 6 59 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 398 Face Mask ( Goggles, Protective , Surgical) PCS 0 960 960 0 960 960 399 Face caps Pcs 0 54 0 54 400 Face Mask - Surgical, Medline PCS 0 4,920 4920 0 4920 4920 401 Face Mask ( 3M Respirator) PCS 0 7,680 7680 0 7680 7680 402 Face Mask ( 3M- Tie- on ) PCS 0 16,200 16200 0 16200 16200 403 Face Mask ( 3M- Tie- on )-Loose PCS 0 32,800 32800 0 32800 32800 404 Face Mask ( Ear loop Shield) PCS 0 400 400 0 400 400 405 Face Mask ( Goggle, Protective, Surgical) PCS 0 12,100 12100 0 12100 12100 406 Face Mask ( Medical Protective) PCS 0 50 50 0 50 50 407 Face Mask ( Protective ) PCS 0 400 400 0 400 400 408 Face Mask ( Smart Seal Surgical) PCS 0 4,200 4200 0 4200 4200 409 Face Mask ( Surgical) Kimberly Clark PCS 0 900 900 0 900 900 410 Face Mask (N-95 Particulate- 3M) PCS 0 20,000 20000 0 20000 20000 411 Face Mask (N-95 Respirator) 4 Pannel PCS 0 3,500 3500 0 3500 3500 412 Face Mask (Respirator) PCS 0 400 400 0 400 400 413 Face Mask (Tecnol Procedure) PCS 0 500 500 0 500 500 414 Face mask ear loop with shield pcs 0 0 1400 0 1400 415 Face Mask( Fluid Shield Fog- Free) PCS 0 800 800 0 800 800 416 FACEMASK (HONEYWELL) PCS 0 7,800 7800 0 7800 7800 417 Facial Tissue ( Board Walk ) CRT 0 352 352 0 352 352 418 Fleece blanket- Dark green and Claret/garnet PCS 0 996 996 0 996 996 419 Floor towel Pcs 0 0 9 45 54 420 FLOOR TOWEL SCRUB PCS 0 103 103 0 103 103 421 FOLIODRESS GOWN L/S PCS 0 308 308 0 308 308 422 FOLIODRESS GOWN XL/S PCS 0 224 224 0 224 224 423 Gloves Heavy duty Pair 0 2,416 2416 0 2416 2416 424 Gloves Heavy duty, rubber/nitrile ( Atlas, Large ) Pair 0 60 60 0 60 60 425 Gloves Heavy duty, rubber/nitrile , ( L )-Clean Expert Pair 0 1,872 1872 0 1872 1872 426 Gloves Heavy duty, rubber/nitrile pair L PCS 0 120 120 0 120 120 427 Gloves Heavy duty, rubber/nitrile pair M PCS 0 300 300 0 300 300 428 Gloves Heavy duty, rubber/nitrile pair S PCS 0 80 80 0 80 80 429 Gloves, Non-sterile Pair 0 1,000 1000 0 1000 1000 430 Goggle pcs 151 151 447 755 1202 431 GOGGLE CLEANER PCS 0 100 100 0 100 100 432 Goggles Safety ( Uvex) PCS 0 300 300 0 300 300 60 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 433 Goggles Safety ( Proviz Gard) PKS 0 156 156 0 156 156 434 Goggles Safety ( Pyramex ) PCS 0 2,453 2453 0 2453 2453 435 Goggles, Chemical Splash Vent Caps CRT 0 325 325 0 325 325 436 Goggles, Masks, And Face Protection PACK 0 2,880 2880 0 2880 2880 437 Goggles, Masks, And Face Protection PACK 0 12,100 12100 0 12100 12100 438 Golggles Safety PCS 0 40 40 0 40 40 439 Gown Foliodress pcs 0 1040 0 1040 440 Gown Polywear - R pcs 0 1400 1300 2700 441 Gowns, Patient, Inc Paper, Protector Cover-up PCS 0 120 120 0 120 120 442 Gowns, Surgical, Non-sterile PCS 0 386 386 0 386 386 443 Gowns, Surgical, Sterile PCS 0 676 676 0 676 676 444 GREEN APRON (RUBBER) PCS 0 205 205 0 205 205 445 Gueney Cover Dispos( Euipment Cover) PCS 0 288 288 0 288 288 446 Gurney (Gurney Kits) PCS 0 500 500 0 500 500 447 Gurney Cover Pcs 0 6 0 6 448 Hair cover/hood pcs 6000 6000 200 7900 8100 449 Hand Sanitizer btts 24 24 4795 1752 6547 450 Hand sanitizer (500 ml bottles) bts. 0 2,418 2418 0 2418 2418 451 Hard brush Pcs 0 7 5 12 452 HEAD CAP / BOUFFANT ( Green ) Pair 0 0 0 0 0 453 Heavy duty gloves Pairs 0 334 244 578 454 Hood (TYVEK) Pcs 0 1385 0 1385 455 Hydrated Lime bag 0 8 0 8 456 INDUSTRIAL GLOVES Pair 0 448 448 0 448 448 457 Insect killer can 0 29 0 29 458 INSECT SPRAY GUN CAN( Killer) CAN 0 45 45 0 45 45 459 Ioban 2 Antimicrobial Incise Drape, Sterile PCS 0 3,920 3920 0 3920 3920 460 Isolation gown (yellow)/Basic PPE Pcs 0 1560 2225 3785 461 Isolation Gown with Thumbloop 100ea size Large Polywear - Caloloympic (large: 42 cases of blue, 100/case; XL: 16 cases of blue, 100/case) pcs 0 4,200 4200 0 4200 4200 462 Isolation Gown with Thumbloop 100ea size Regular, Polywear - Calolympic PCS 0 2,392 2392 0 2392 2392 463 ISOLATION GOWN YELLOW ( Disposable Surgical Gown ) PCS 0 100 100 0 100 100 464 Jerrycans Plastic, 1L PCS 0 508 508 0 508 508 465 Kitchen Mate Gal 0 5 5 0 5 5 61 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 466 Klin powder soap sachet 0 1344 72 1416 467 Lab Coat Pcs 0 20 0 20 468 Lab Coats And Tunics, Scrub Suits, Surgical PCS 0 436 436 0 436 436 469 Lab Supply Kit, Abg Syringes & Culture Supplies KIT 0 2 2 0 2 2 470 Lab Supply Kit, General Lab Supplies KIT 0 2 2 0 2 2 471 Lab Supply Kit, Vacutainer Tubes KIT 0 2 2 0 2 2 472 Mask (3M) Pcs 0 670 1440 2110 473 Mask earloop with shield Pcs 0 100 0 100 474 Mask Respirator N-95 Pcs 0 1505 0 1505 475 Mattress pcs 0 5 8 13 476 Measuring jugs PCS 0 60 60 0 60 60 477 Med comfort pe apron (light) PCS 0 700 700 0 700 700 478 Medical supplies (action medeor) pvc/nitril boots (white) PCS 0 311 311 0 311 311 479 Medical supplies (ida) plastic corpse/ body bags (white) pcs 0 1,190 1190 0 1190 1190 480 Medical supplies (ida) pvc boots (black) pcs 0 110 110 0 110 110 481 Medical supplies (imres) black sagety boots (pvc) pcs 0 107 107 0 107 107 482 Medical supplies (imres) body bag ( black) PCS 0 1,294 1294 0 1294 1294 483 Medical supplies (imres) body bag (white)-zipper pcs 0 1,200 1200 0 1200 1200 484 Medical supplies (imres) nose mask PCS 0 30 30 0 30 30 485 Medication cups PCS 0 385 385 0 385 385 486 Mop bucket Pcs 0 3 0 3 487 Mop head Pcs 0 4 0 4 488 Mopper broom pcs 0 10 0 10 489 Mosquito Netting CASES 0 12 12 0 12 12 490 Mosquito Netting ( White ) CASES 0 62 62 0 62 62 491 Mr. Clean Liquid soap btts 1 1 222 0 222 492 N-95 Particulate Respirator and Surgical Mask ( Yellow ) PCS 0 90000 90000 0 90000 90000 493 Napkin folder folder 0 237 0 237 494 Napkin roll Roll 0 3 0 3 495 Paper Towel Pcs 0 189 250 439 496 Patient Supplies kit PCS 0 3 3 0 3 3 497 Pillow case/cover PCS 0 51 51 0 51 51 498 Plastic apron Pcs 0 974 0 974 62 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 499 Plastic roll (white) ROLL 0 3 3 0 3 3 500 Plastic sheets Pcs 0 4 0 4 501 Plastic table cover PCS. 0 56 56 0 56 56 502 Plastic tubs (large size) PCS 0 9 9 0 9 9 503 Plastic tubs (medium size) PCS 0 10 10 0 10 10 504 Ploywear-R Pcs 0 1270 3775 5045 505 PPE Enhanced pcs 0 1485 650 2135 506 PPE- Top Guard ( Large) PCS 0 1,900 1900 0 1900 1900 507 PPE -Top Guard ( Medium) PCS 0 375 375 0 375 375 508 PPE -Top Guard ( XL) PCS 0 1,600 1600 0 1600 1600 509 PPE- Tyvek Hood ( Medium) PCS 0 225 225 0 225 225 510 PPE- Tyvek Suit ( Large) PCS 0 400 400 0 400 400 511 PPE- Tyvek Suit ( XL) PCS 0 625 625 0 625 625 512 PPE -Tyvex Suit (Medium) PCS 0 700 700 0 700 700 513 Prep Brush pcs 0 0 714 714 514 PVC CLING FILM PCS 0 8 8 0 8 8 515 Rainboot Pairs 0 181 24 205 516 Ready-bath pcs 0 63 63 0 63 63 517 RESPIRATOR PARTICULATE HEATHCARE FACEMASK PCS 0 480 480 0 480 480 518 RESTRAIN PATIENT BOX 0 37 37 0 37 37 519 Re-usable apron pcs 0 26 192 218 520 Rubber cup Pcs 0 56 0 56 521 Rubber Cup Pcs 0 82 82 0 82 82 522 Rubber plate pcs 0 183 0 183 523 Rubber spoon Pcs 0 25 0 25 524 SAFETY GOGGLES PCS 0 328 328 0 328 328 525 Safety Pin PKs 0 0 0 0 0 526 Sanitary pad Pcs 0 20 0 20 527 Scrub Brushes and Skin Prep Sets PCS 0 556 556 0 556 556 528 Scrub care/povidine pcs 0 0 711 711 529 SCRUBS Suit (S, M, L) set: top/bottom pcs 361 361 60 361 421 530 Secure comfort tape PCS 0 250 250 0 250 250 531 Sensi care power examination gloves (l) PCS 0 4,000 4000 0 4000 4000 532 Sensi care power examination gloves (m) PCS 0 20,000 20000 0 20000 20000 533 Sharp container Pcs 0 19 33 52 534 Sharps collector glove box each 0 6 6 0 6 6 535 Sharps container wall mount unit each 0 35 35 0 35 35 536 Sharps Containers, Send Only w/ Lids each 0 546 546 0 546 546 63 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 537 Shoe cover pcs 0 1966 600 2566 538 Shoes cover machine PCS 0 1 1 0 1 1 539 Shower slippers PCS. 0 95 95 0 95 95 540 Skin barrier wipes CRT 0 4 4 0 4 4 541 Skin specialties PCS 0 58 58 0 58 58 542 Slippers Pairs 0 2 0 2 543 Soap bar 200gm Cakes 0 257 257 0 257 257 544 Soft broom Pcs 0 30 0 30 545 Soft scrub (bleach cleanser) PCS 0 30 30 0 30 30 546 Soft soap/ hand soap btts 0 7 7 0 7 7 547 Specimen bag pcs 0 200 0 200 548 Specimen container pcs 0 0 10 10 549 Specimen tube pcs 0 50 0 50 550 Split peas bag 0 3 0 3 551 Sponges pcs 0 0 27 27 552 Sprayer 1 Liter CAN 0 15 15 0 15 15 553 Sprayer disinfectant 10 Liters CAN 0 10 10 0 10 10 554 Sprayer disinfectant 10L CAN 0 6 6 0 6 6 555 Spraying can CAN 0 2 2 0 2 2 556 Spraying can (1liter) Pcs 0 0 24 0 24 557 Spraying Can (Large) Pcs 0 0 6 0 6 558 Sterilization, Tapes, Indicators, Wraps & Pouches PCS 0 1,174 1174 0 1174 1174 559 Surgical apron (light yellow) pcs 0 600 600 0 600 600 560 Surgical caps, hats and shoes cover PCS 0 500 500 0 500 500 561 Tarpaulin box 0 23 6 29 562 Tissue Roll 0 980 36 1016 563 Tissue weib PCS 0 16 16 0 16 16 564 Toothbrush Pcs 16 16 73 16 89 565 Toothpaste pack 15 15 70 15 85 566 Tournequet PCS 0 200 200 0 200 200 567 Towel Pcs 0 21 3 24 568 Trash bag pcs 0 7827 2000 9827 569 Trash bag ( black) PCS 0 2,472 2472 0 2472 2472 570 Trash bag ( white) PCS 0 1,500 1500 0 1500 1500 571 Tyvek hood ( dupont personal protection) PCS 0 2,300 2300 0 2300 2300 572 Under clothes (woman) pcs 0 6 0 6 573 Vinyl Bed Surface (Camp Bed) PCS 0 19 19 0 19 19 574 Vinyl bed/ camp bed Pcs 0 5 0 5 575 Vita cube Pcs 0 900 0 900 576 Walker, Folding each 0 4 4 0 4 4 64 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 577 WARNING TAPE ROLL 0 2 2 0 2 2 578 Washing Soap Cakes 0 1079 0 1079 579 WATER PLASTIC CONTAINER PCS 0 21 21 0 21 21 580 WOVEN TARPAULIN BOXES 0 80 80 0 80 80 Medical and IPC Equipment 581 3-way stop cock pcs 0 0 0 0 126 126 582 4-way stop cock Pcs 0 0 0 0 50 50 583 Ambu bag Pcs 0 26 26 9 26 35 584 Assorted IV tubing pcs 0 0 0 0 101 101 585 Assorted Laboratory Materials Ctn 0 0 0 0 2 2 586 Baby Scale Pcs 0 0 0 0 1 1 587 BACK PACK SPRAYER CAN ( 12L) can 0 25 25 4 25 29 588 Bandage roll 0 0 0 15 0 15 589 Barrel (large) Pcs 0 0 0 7 0 7 590 Barrel (XL) pcs 0 0 0 15 0 15 591 Barrel Medium) pcs 0 0 0 12 0 12 592 Bed Pan ( Round Wash Basin)-Blue PCS 0 60 60 0 60 60 593 Bed pan ((IMRES) adult size pcs 0 250 250 0 250 250 594 BED PAN (PLASTIC) with lid and handles PCS 0 100 100 0 100 100 595 Bedpans And Urinals pcs 0 200 200 0 200 200 596 Blood Collection Tubes tubes 0 137 137 0 137 137 597 Bowl, stainless steel, 180ml PCS. 0 60 60 0 60 60 598 BP cuff Pcs 0 10 26 36 599 BREAST PUMP PCS 0 3 3 0 3 3 600 BREAST RELIEVER PCS 0 2 2 0 2 2 601 Bucket (faucet) Pcs 0 75 45 120 602 Bucket (small) Pcs 0 160 27 187 603 Bucket (White with Lid) Pcs 0 1 0 1 604 Container 5L (black) pcs 0 3 0 3 605 Cooling vast pcs 0 26 26 0 26 26 606 Cooling Vest Pcs 0 65 0 65 607 Dust pan Pcs 0 3 0 3 608 Electronic scale (bath room type) PC 0 2 2 0 2 2 609 Empty spray can(1 litre) PCS 0 20 20 0 20 20 610 Funnel Psc 0 10 10 0 10 10 611 Glucose Meter PCS 0 1 1 0 1 1 612 Hard brush pcs 0 4 0 4 613 IR thermometer Pcs 60 60 10 90 100 614 IV Extension & Secondary Tubing sqm 0 1,728 1728 0 1728 1728 615 IV Pole each 0 7 7 0 7 7 65 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Item Description Unit Quantity used this quarter (Jan - Mar 2016) Cumulative Jan 2015- Mar 2016 By the ETU Distributed to HF Total By the ETU Distributed to HF Total 616 IV Primary Tubing, Including Blood Tubing each 0 95 95 0 95 95 617 Jerry can (1L) Pcs 0 160 0 160 618 Kidney bean Surgical bowl Pcs 32 32 12 32 44 619 LARYNGNGOSCOPE PC 0 1 1 0 1 1 620 Light, Exam PCS 0 1 1 0 1 1 621 Light, Exam ( Spoiled) PCS 0 1 1 0 1 1 622 Nasal Gastric & Gastric Lavage Tubes & Kits PCS 0 36 36 0 36 36 623 Nebulizer -Machine Box 0 1 1 0 1 1 624 Nebulizer Supplies PCS 0 146 146 0 146 146 625 Needles, Mixed Gauges PCS 0 31 31 0 31 31 626 Oxygen Masks and Tubing PCS 0 4 4 0 4 4 627 Pads, Wedges, Positioning Pillows PCS 0 144 144 0 144 144 628 Patient ID Bracelet PCS 0 4,000 4000 0 4000 4000 629 SPECIMEN CONTAINER PCS 0 740 740 0 740 740 630 Sphygmomanometer BOXES 0 139 139 0 139 139 631 SPRAYER CAN (1LITRE) CAN 0 11 11 0 11 11 632 Stethoscope Pcs 44 44 7 44 51 633 STRETCHER, foldable, alu CRT 0 21 21 0 21 21 634 Suction Canisters & Lids PCS 0 491 491 0 491 491 635 Suction Machine Low Portable Box 0 1 1 0 1 1 636 Suprapubic catheter tray Set 0 0 6 6 637 SURGICAL SCISSORS PCS 0 15 15 0 15 15 638 Temporal Thermometers - Abatix ( Patient Digital) PCS 0 1,913 1913 0 1913 1913 639 THERMOMETER COVER PCS 0 2,000 2000 0 2000 2000 640 Thermometer, Oral each 0 6 6 0 6 6 641 Thermometer, Patient Digital pcs 0 0 31 31 642 Thermometer/flash Pcs 0 4 0 4 643 Urinary Catheters, Trays & Insertion Sets PCS 0 5 5 0 5 5 644 Vena Thermometer pcs 3 3 3 3 6 645 Ventilator Tubing and Supplies each 0 174 174 0 174 174 646 Weighing (Baby)scale -CCC PCS 0 3 3 0 3 3 (Source: STEP program performance report for the period of Jan 1 – Mar 31, 2016; PCI. April 21, 2016) 66 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia Annex 4: List of health facilities Supported by STEP by type of supported S/N Name of Health Facilities /Institutions District Level of HF[1] Type of Support Provided Medical commodities and supplies provision Mentorship Type of training SQS Training12 EVD surveillance and response 13 Safe swab sample collection and transporting14 1 Beoyoola Clinic Gbarlay Geh Primary xxx xxx xxx xxx 2 Gbaelay-geh DHT Gbarlay Geh DHT xxx xxx 3 Duoplay Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 4 Garplay Mission Clinic Gbarlay Geh Primary xxx xxx xxx xxx 5 Gbeivonwea Clinic Gbarlay Geh Primary xxx xxx xxx xxx 6 Give them hope Clinic Gbarlay Geh Primary xxx xxx xxx xxx 7 Gorguatuo Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 8 Karnplay Health Center Gbarlay Geh Primary xxx xxx xxx xxx 9 Kpairplay Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 10 Loguatuo Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 11 Slanganplay Clinic Gbarlay Geh Primary xxx xxx xxx xxx 12 Vayenglay Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 13 Younlay Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 12 At least three service providers from the listed health facilities and County/District offices have been trained on SQS, and the plan is to train 100% of the service providers in each HF. 13 One staff representing the health facilities, DHT, and CHT have benefited from the training 14 At least one lab aid or health service provider is trained per facility. 67 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Name of Health Facilities /Institutions District Level of HF[1] Type of Support Provided Medical commodities and supplies provision Mentorship Type of training SQS Training12 EVD surveillance and response 13 Safe swab sample collection and transporting14 14 Zorgowee Clinic Gbarlay Geh Primary xxx xxx xxx xxx xxx 15 Beindin Clinic Saclepea Mah Primary xxx xxx xxx xxx 16 Bunadin Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 17 Cocopa Clinic Saclepea Mah Primary xxx xxx xxx 18 Sclepea-mah DHT Saclepea Mah DHT xxx xxx 19 Duayee Clinic Saclepea Mah Primary xxx xxx xxx 20 Flumpa Comm. Clinic Saclepea Mah Primary xxx xxx xxx xxx 21 Flumpa ULIC Saclepea Mah Primary xxx xxx xxx xxx xxx 22 Karnwee Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 23 Kpaytuo Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 24 Kpein Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 25 Saclepea Clinic Saclepea Mah Primary xxx 26 Saclepea Com. HC Saclepea Mah Primary xxx xxx xxx xxx xxx 27 Saclepea ULIC Saclepea Mah Primary xxx xxx xxx 28 Tunukpuye Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 29 Zahn Bahnla Clinic Saclepea Mah Primary xxx xxx xxx xxx xxx 30 Duayee (Gbeyi Duayee) clinic Saclepea Mah Primary xxx xxx 31 Docas Matto Memorial Clinic Saclepea Mah Primary xxx xxx xxx xxx 32 Duo Clinic Saclepea Mah Primary xxx xxx xxx xxx 33 Kpallah Saclepea Mah Primary xxx xxx 34 Agape Clinic Sanniquelle Mah Primary xxx xxx xxx 35 Arcelor Mittal Yekepa Hosp. Sanniquelle Mah secondary xxx xxx xxx xxx xxx 68 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Name of Health Facilities /Institutions District Level of HF[1] Type of Support Provided Medical commodities and supplies provision Mentorship Type of training SQS Training12 EVD surveillance and response 13 Safe swab sample collection and transporting14 36 Bomah Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 37 CHT Emergency Pharmacy Sanniquelle Mah CHT xxx xxx 38 Nimba CHT Sanniquelle Mah CHT xxx xxx 39 Sanniquelle-mah DHT Sanniquelle Mah DHT xxx xxx 40 Duotiayee Clinic Sanniquelle Mah Primary xxx xxx xxx xxx xxx 41 Evening Star Clinic Sanniquelle Mah Primary xxx xxx xxx 42 Free penticostal Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 43 G.W.Harley Hospital Sanniquelle Mah tertiary xxx xxx xxx xxx xxx 44 Gant ETU Sanniquelle Mah tertiary xxx xxx xxx xxx 45 Ganta Comm. Clinic Sanniquelle Mah Primary xxx xxx xxx xxx xxx 46 Ganta Equip Clinic Sanniquelle Mah Primary xxx xxx xxx xxx xxx 47 Ganta Methodoest Hospital Sanniquelle Mah Tertiary xxx xxx xxx xxx xxx 48 Ganta Rehab. Hospital Sanniquelle Mah Secondary xxx xxx xxx xxx xxx 49 J. Kohn Hosp. Sanniquelle Mah secondary xxx xxx 50 KL Foundation Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 51 Kozomoway Med. Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 52 Lugbeyee Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 53 Newman Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 54 Power House Clinic Sanniquelle Mah Primary xxx xxx xxx xxx xxx 55 St. Mary's Clinic Sanniquelle Mah Primary xxx xxx xxx xxx 56 YMCA Clinic Sanniquelle Mah Primary xxx xxx xxx xxx xxx 57 Bonlay Clinic Tappita Primary xxx xxx xxx xxx xxx 69 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Name of Health Facilities /Institutions District Level of HF[1] Type of Support Provided Medical commodities and supplies provision Mentorship Type of training SQS Training12 EVD surveillance and response 13 Safe swab sample collection and transporting14 58 Consoleta Clinic Tappita Primary xxx xxx xxx xxx 59 Tappita DHT Tappita DHT xxx xxx 60 Dilla (Gblor Dialla) Clinic Tappita Primary xxx xxx xxx xxx xxx 61 Glahn Town Clinic Tappita Primary xxx xxx xxx xxx 62 Graie Clinic Tappita Primary xxx xxx xxx xxx 63 JFD Hospital Tappita Tertiary xxx xxx xxx xxx 64 Mid-Baptist Clinic Tappita Primary xxx xxx xxx xxx xxx 65 New Yourpea Clinic Tappita Primary xxx xxx xxx xxx 66 Toweh Town Clinic Tappita Primary xxx xxx xxx 67 Zuaplay Clinic Tappita Primary xxx xxx xxx xxx xxx 68 Zuolay Clinic Tappita Primary xxx xxx xxx xxx xxx 69 YM DHT Yarwin Mehnsonnoh DHT xxx xxx 70 Kwendin Clinic Yarwin Mehnsonnoh Primary xxx xxx xxx xxx 71 Mehnla Clinic Yarwin Mehnsonnoh Primary xxx xxx xxx xxx xxx 72 Zekepa Clinic Yarwin Mehnsonnoh Primary xxx xxx xxx 73 Zekepa H. Center Yarwin Mehnsonnoh Primary xxx xxx xxx xxx 74 Boyee Clinic Yarwin Mehnsonnoh Primary xxx xxx 75 Bahn AHA Camp Clinic Zoe-Geh Primary xxx xxx xxx xxx 76 Bahn Health Center Zoe-Geh Primary xxx xxx xxx xxx xxx 70 | Page USAID/OFDA funded Support To Ebola Treatment Unit Project End-Line Evaluation Report 2016, PCI Liberia S/N Name of Health Facilities /Institutions District Level of HF[1] Type of Support Provided Medical commodities and supplies provision Mentorship Type of training SQS Training12 EVD surveillance and response 13 Safe swab sample collection and transporting14 77 Bahn ULIC Zoe-Geh Primary xxx xxx xxx xxx xxx 78 Beadatuo Clinic Zoe-Geh Primary xxx xxx xxx xxx 79 Buutuo Clinic Zoe-Geh Primary xxx xxx xxx xxx 80 Buutuo United Lib Inland Clinic Zoe-Geh Primary xxx xxx xxx xxx 81 Zoe-geh DHT Zoe-Geh DHT xxx xxx 82 Gblarlay Clinic Zoe-Geh Primary xxx xxx xxx xxx xxx 83 Lapula Clinic Zoe-Geh Primary xxx xxx xxx xxx 84 Payee Clinic Zoe-Geh Primary xxx xxx xxx xxx 85 Wehplay Clinic Zoe-Geh Primary xxx xxx xxx xxx 86 Zoe-Geh M. Center Zoe-Geh Primary xxx xxx xxx 87 Gbloulay Clinic Zoe-Geh District Primary xxx xxx xxx xxx Source: summarized from STEP quarterly program performance reports for the period of Jul 1 – Sept 30, 2015; Jul 1 – Sept 30, 2015; and Jan 1 – Mar 31, 2016; PCI.